id	sid	tid	token	lemma	pos
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	1	RESEARCH	research	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	2	Open	open	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	3	Access	access	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	4	Does	do	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	6	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	8	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	9	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	10	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	11	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	13	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	14	Union	Union	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	15	address	address	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	16	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	18	regional	regional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	19	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	20	concerns	concern	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	1	21	?	?	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	1	Ferrán	Ferrán	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	2	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	3	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	4	López,1,2	López,1,2	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	5	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	7	Anna	Anna	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	8	García	García	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	9	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	10	Altés,1,3	Altés,1,3	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	12	Elena	Elena	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	13	Álvarez	Álvarez	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	14	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	15	Martín4	Martín4	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	17	Ricard	Ricard	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	18	Gènova	Gènova	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	19	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	20	Maleras5	Maleras5	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	22	Consuelo	Consuelo	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	23	Morant	Morant	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	24	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	25	Ginestar6	Ginestar6	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	26	Abstract	Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	27	Background	Background	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	28	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	29	Since	since	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	30	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	31	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	32	approval	approval	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	33	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	34	many	many	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	35	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	36	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	37	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	38	has	have	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	39	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	40	obtained	obtain	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	41	through	through	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	42	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	43	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	44	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	45	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	46	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	47	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	48	Union	Union	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	2	49	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	2	recent	recent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	3	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	6	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	8	summary	summary	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	9	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	11	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	12	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	13	has	have	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	14	become	become	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	15	widespread	widespread	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	3	16	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	2	investigated	investigate	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	3	whether	whether	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	4	efforts	effort	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	5	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	6	develop	develop	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	7	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	8	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	9	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	10	focusing	focus	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	11	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	13	most	most	RBS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	14	relevant	relevant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	15	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	16	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	17	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	18	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	19	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	20	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	21	perspective	perspective	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	4	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	1	Methods	method	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	2	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	3	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	4	reviewed	review	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	6	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	7	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	8	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	9	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	10	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	11	approved	approve	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	12	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	13	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	14	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	15	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	16	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	17	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	18	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	20	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	21	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	22	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	23	available	available	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	24	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	25	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	26	public	public	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	27	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	28	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	29	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	30	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	31	Register	Register	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	32	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	33	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	34	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	35	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	36	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	37	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	38	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	39	Assessment	Assessment	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	40	Reports	report	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	41	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	42	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	43	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	44	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	45	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	5	46	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	1	Morbidity	morbidity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	2	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	3	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	4	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	5	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	6	included	include	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	7	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	8	each	each	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	9	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	10	group	group	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	12	according	accord	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	13	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	15	Global	Global	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	16	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	17	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	18	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	19	project	project	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	6	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	2	evaluated	evaluate	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	4	association	association	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	5	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	6	authorized	authorized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	7	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	8	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	10	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	11	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	12	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	13	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	14	based	base	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	15	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	16	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	17	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	18	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	19	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	20	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	21	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	22	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	23	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	24	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	25	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	26	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	27	Union	Union	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	28	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	29	worldwide	worldwide	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	7	30	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	1	Results	result	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	2	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	3	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	4	considered	consider	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	5	520	520	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	6	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	7	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	8	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	9	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	10	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	11	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	12	338	338	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	13	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	14	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	8	15	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	1	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	2	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	3	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	4	seen	see	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	5	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	6	increase	increase	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	7	over	over	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	8	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	9	period	period	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	10	analyzed	analyze	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	9	11	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	1	There	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	2	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	3	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	4	positive	positive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	6	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	7	correlation	correlation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	8	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	9	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	10	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	11	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	12	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	13	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	14	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	15	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	16	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	17	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	18	0.619	0.619	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	20	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	21	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	22	0.005	0.005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	23	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	24	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	25	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	26	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	27	Union	Union	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	28	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	29	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	30	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	31	moderate	moderate	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	32	correlation	correlation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	33	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	34	middle	middle	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	35	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	36	low	low	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	37	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	38	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	39	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	40	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	41	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	42	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	43	0.497	0.497	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	44	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	45	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	46	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	47	0.030	0.030	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	48	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	49	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	50	worldwide	worldwide	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	51	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	52	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	53	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	54	0.490	0.490	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	55	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	56	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	57	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	58	0.033	0.033	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	59	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	10	60	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	2	most	most	RBS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	3	neglected	neglected	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	4	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	5	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	7	European	european	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	8	level	level	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	9	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	10	based	base	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	11	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	12	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	13	attributable	attributable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	14	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	15	losses	loss	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	16	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	17	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	18	neuropsychiatric	neuropsychiatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	19	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	20	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	21	cardiovascular	cardiovascular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	22	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	23	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	24	respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	25	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	26	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	27	sense	sense	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	28	organ	organ	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	29	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	31	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	32	digestive	digestive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	33	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	34	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	35	while	while	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	36	globally	globally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	37	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	38	they	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	39	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	40	perinatal	perinatal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	41	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	42	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	43	respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	44	infections	infection	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	45	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	46	sense	sense	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	47	organ	organ	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	48	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	49	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	50	respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	51	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	52	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	53	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	54	digestive	digestive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	55	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	11	56	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	1	Conclusions	conclusion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	2	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	3	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	4	find	find	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	5	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	7	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	9	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	10	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	11	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	12	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	13	higher	high	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	14	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	15	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	16	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	17	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	18	others	other	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	12	19	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	1	Pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	2	industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	3	leaders	leader	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	4	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	5	policymakers	policymaker	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	6	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	7	invited	invite	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	8	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	9	consider	consider	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	11	implications	implication	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	12	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	13	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	14	imbalance	imbalance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	15	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	16	establishing	establish	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	17	work	work	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	18	plans	plan	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	19	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	20	allow	allow	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	21	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	22	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	23	setting	setting	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	24	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	25	future	future	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	26	priorities	priority	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	27	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	28	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	29	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	30	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	31	perspective	perspective	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	13	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	1	Background	Background	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	2	Medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	3	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	4	policies	policy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	5	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	6	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	7	challenging	challenging	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	8	field	field	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	9	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	10	cur-	cur-	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	11	rent	rent	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	12	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	13	policy	policy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	14	14	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	1	Medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	2	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	3	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	4	major	major	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	5	determining	determine	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	6	factor	factor	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	8	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	9	health	health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	10	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	11	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	12	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	14	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	15	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	16	current	current	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	17	capacity	capacity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	18	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	19	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	20	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	21	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	22	prevent	prevent	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	23	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	24	discontinue	discontinue	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	26	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	27	modify	modify	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	28	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	29	natural	natural	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	30	course	course	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	31	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	32	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	33	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	34	reduce	reduce	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	35	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	36	symptoms	symptom	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	37	depends	depend	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	38	mostly	mostly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	39	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	40	them	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	15	41	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	2	pharmaceutical	pharmaceutical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	3	industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	4	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	5	one	one	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	6	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	8	most	most	RBS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	9	potent	potent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	10	industrial	industrial	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	11	sectors	sector	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	12	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	13	developed	develop	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	14	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	16	having	have	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	17	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	18	major	major	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	19	impact	impact	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	20	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	21	national	national	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	22	economies	economy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	23	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	24	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	25	creation	creation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	26	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	27	employment	employment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	28	opportunities	opportunity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	29	as	as	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	30	well	well	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	31	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	32	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	33	invest-	invest-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	34	ment	ment	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	35	policies	policy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	16	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	1	A	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	2	proxy	proxy	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	3	variable	variable	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	4	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	5	establish	establish	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	6	pharmaceu-	pharmaceu-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	7	tical	tical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	8	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	9	success	success	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	10	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	12	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	14	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	15	granted	grant	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	16	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	17	marketing	market	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	18	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	19	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	17	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	1	Regulatory	regulatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	2	authorities	authority	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	3	generally	generally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	4	judge	judge	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	6	suitability	suitability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	8	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	9	treat-	treat-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	10	ments	ment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	11	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	12	terms	term	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	15	benefit	benefit	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	16	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	17	risk	risk	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	18	balance	balance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	19	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	20	regulate	regulate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	21	commercialization	commercialization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	22	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	23	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	24	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	25	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	26	based	base	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	27	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	28	qual-	qual-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	29	ity	ity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	31	safety	safety	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	32	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	33	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	34	efficacy	efficacy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	35	criteria	criterion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	18	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	2	benefit	benefit	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	4	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	5	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	6	Correspondence	correspondence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	8	ferran_catala@hotmail.com	ferran_catala@hotmail.com	ADD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	9	1Fundación	1Fundación	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	10	Instituto	Instituto	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	11	de	de	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	12	Investigación	Investigación	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	13	en	en	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	14	Servicios	Servicios	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	15	de	de	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	16	Salud	Salud	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	17	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	18	Valencia	Valencia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	20	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	21	Full	Full	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	22	list	list	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	23	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	24	author	author	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	25	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	26	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	27	available	available	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	28	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	29	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	30	end	end	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	31	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	32	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	33	article	article	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	34	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	35	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	36	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	37	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	38	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	39	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	19	40	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	8	©	©	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	9	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	10	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	11	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	12	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	14	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	15	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	16	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	17	licensee	licensee	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	18	BioMed	BioMed	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	19	Central	Central	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	20	20	Ltd.	Ltd.	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	1	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	2	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	3	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	4	Open	open	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	5	Access	access	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	6	article	article	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	7	distributed	distribute	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	8	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	9	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	10	terms	term	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	11	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	13	Creative	Creative	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	14	Commons	Commons	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	15	Attribution	Attribution	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	16	License	License	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	17	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	18	http://creativecommons.org/licenses/by/2.0	http://creativecommons.org/licenses/by/2.0	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	19	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	20	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	21	which	which	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	22	permits	permit	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	23	unrestricted	unrestricted	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	24	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	26	distribution	distribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	27	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	28	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	29	reproduction	reproduction	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	30	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	31	any	any	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	32	medium	medium	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	33	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	34	provided	provide	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	35	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	36	original	original	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	37	work	work	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	38	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	39	properly	properly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	40	cited	cite	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	21	41	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	1	mailto:ferran_catala@hotmail.com	mailto:ferran_catala@hotmail.com	UH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	2	http://creativecommons.org/licenses/by/2.0	http://creativecommons.org/licenses/by/2.0	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	3	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	4	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	5	if	if	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	6	they	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	7	do	do	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	8	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	9	harm	harm	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	10	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	11	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	12	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	13	viewed	view	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	14	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	15	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	16	decrease	decrease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	17	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	18	disease	disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	19	burden	burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	20	associated	associate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	21	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	22	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	23	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	24	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	25	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	26	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	27	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	28	though	though	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	29	additional	additional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	30	criteria	criterion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	31	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	32	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	33	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	34	considered	consider	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	35	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	36	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	37	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	38	degree	degree	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	39	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	40	innovation	innovation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	41	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	42	cost	cost	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	43	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	44	effectiveness	effectiveness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	45	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	46	added	add	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	47	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	48	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	49	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	50	existence	existence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	51	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	52	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	53	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	54	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	55	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	56	options	option	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	57	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	58	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	59	same	same	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	60	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	61	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	62	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	63	specific	specific	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	64	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	65	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	66	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	67	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	68	groups	group	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	69	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	22	70	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	1	Since	since	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	2	early	early	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	3	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	5	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	6	Union	Union	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	7	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	8	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	9	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	10	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	11	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	12	many	many	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	13	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	14	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	15	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	16	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	17	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	18	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	19	has	have	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	20	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	21	obtained	obtain	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	22	through	through	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	23	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	24	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	25	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	23	26	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	1	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	2	proce-	proce-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	3	dure	dure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	5	managed	manage	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	6	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	8	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	9	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	10	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	12	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	13	mandatory	mandatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	14	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	15	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	16	derived	derive	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	17	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	18	biotechnology	biotechnology	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	19	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	20	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	21	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	22	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	23	technology	technology	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	24	procedures	procedure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	26	those	those	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	27	aimed	aim	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	28	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	29	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	30	treatment	treatment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	31	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	32	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	33	immunodeficiency	immunodeficiency	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	34	virus	virus	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	35	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	36	acquired	acquire	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	37	immunodeficiency	immunodeficiency	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	38	syndrome	syndrome	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	39	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	40	HIV	HIV	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	41	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	42	AIDS	AIDS	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	43	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	44	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	45	cancer	cancer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	46	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	47	dia-	dia-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	48	betes	betes	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	49	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	50	neurodegenerative	neurodegenerative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	51	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	52	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	53	autoimmune	autoimmune	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	54	disor-	disor-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	55	ders	ders	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	56	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	57	viral	viral	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	58	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	59	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	60	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	61	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	62	orphan	orphan	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	63	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	64	used	use	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	65	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	66	treat	treat	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	67	rare	rare	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	68	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	24	69	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	2	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	3	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	4	appli-	appli-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	5	cation	cation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	6	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	7	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	8	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	9	submitted	submit	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	10	whenever	whenever	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	12	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	13	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	14	involved	involve	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	15	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	16	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	17	major	major	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	18	therapeutic	therapeutic	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	20	scientific	scientific	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	22	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	23	technical	technical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	24	innovation	innovation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	26	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	27	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	28	relevant	relevant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	29	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	30	any	any	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	31	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	32	way	way	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	33	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	34	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	35	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	36	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	37	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	38	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	25	39	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	2	existence	existence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	4	limited	limited	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	5	resources	resource	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	6	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	7	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	9	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	10	activities	activity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	12	together	together	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	13	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	14	budget	budget	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	15	restrictions	restriction	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	16	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	17	funding	funding	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	18	approved	approve	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	19	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	20	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	22	require	require	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	23	estab-	estab-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	24	lishing	lishe	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	25	explicit	explicit	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	26	criteria	criterion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	27	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	28	guide	guide	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	29	debates	debate	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	30	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	31	priority	priority	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	32	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	33	set-	set-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	34	ting	ting	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	26	35	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	2	recent	recent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	3	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	6	calculation	calculation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	7	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	8	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	10	summary	summary	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	11	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	12	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	13	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	14	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	15	have	have	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	16	become	become	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	17	widespread	widespread	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	18	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	19	influential	influential	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	20	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	21	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	22	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	23	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	24	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	25	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	26	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	27	case	case	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	28	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	29	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	30	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	31	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	32	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	33	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	34	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	35	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	36	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	37	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	38	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	39	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	27	40	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	1	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	2	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	3	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	4	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	5	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	6	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	7	condition	condition	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	8	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	9	calculated	calculate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	10	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	12	sum	sum	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	14	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	15	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	16	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	17	lost	lose	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	18	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	19	YLL	YLL	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	20	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	21	due	due	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	22	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	23	premature	premature	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	24	mortal-	mortal-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	25	ity	ity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	26	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	27	relation	relation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	28	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	29	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	30	expectancy	expectancy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	31	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	32	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	33	lived	live	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	34	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	35	dis-	dis-	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	36	ability	ability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	37	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	38	YLD	YLD	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	39	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	28	40	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	1	One	one	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	2	DALY	DALY	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	3	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	4	equivalent	equivalent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	5	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	7	loss	loss	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	9	one	one	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	10	year	year	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	11	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	12	healthy	healthy	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	13	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	29	14	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	1	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	2	allow	allow	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	4	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	5	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	6	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	7	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	8	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	9	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	10	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	11	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	12	measured	measure	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	13	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	15	gap	gap	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	16	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	17	cur-	cur-	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	18	rent	rent	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	19	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	20	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	21	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	22	ideal	ideal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	23	situation	situation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	24	where	where	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	25	everyone	everyone	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	26	lives	live	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	27	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	28	old	old	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	29	age	age	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	31	free	free	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	32	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	33	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	34	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	35	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	30	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	1	It	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	2	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	3	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	4	indica-	indica-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	5	tion	tion	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	6	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	8	unfinished	unfinished	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	9	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	10	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	11	agenda	agenda	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	12	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	13	identi-	identi-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	14	fies	fie	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	15	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	16	where	where	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	17	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	18	gains	gain	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	19	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	20	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	21	made	make	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	22	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	23	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	24	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	31	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	1	Thus	thus	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	3	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	4	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	5	designed	design	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	6	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	7	guide	guide	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	8	investment	investment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	9	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	10	policies	policy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	11	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	12	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	13	inform	inform	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	14	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	15	priority	priority	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	16	setting	setting	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	17	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	18	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	19	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	20	activities	activity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	21	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	22	6,7	6,7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	23	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	32	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	2	aim	aim	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	4	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	5	paper	paper	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	6	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	7	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	8	examine	examine	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	9	whether	whether	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	10	medi-	medi-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	11	cines	cine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	12	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	13	activities	activity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	14	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	15	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	16	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	17	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	18	aimed	aim	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	19	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	20	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	21	most	most	RBS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	22	relevant	relevant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	23	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	24	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	25	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	26	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	27	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	28	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	29	perspective	perspective	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	31	considering	consider	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	32	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	33	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	34	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	35	criteria	criterion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	33	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	1	Methods	Methods	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	2	Study	Study	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	3	design	design	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	4	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	5	data	data	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	6	sources	source	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	7	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	8	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	9	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	10	observational	observational	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	12	cross	cross	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	13	-	-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	14	sectional	sectional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	15	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	16	evaluating	evaluate	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	18	association	association	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	19	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	20	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	21	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	22	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	23	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	24	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	25	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	26	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	27	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	28	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	29	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	30	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	31	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	32	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	33	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	34	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	35	establishing	establish	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	36	whether	whether	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	37	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	38	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	39	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	40	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	41	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	42	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	43	changes	change	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	44	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	45	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	46	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	47	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	48	dif-	dif-	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	49	ferent	ferent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	50	populations	population	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	34	51	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	1	With	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	2	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	3	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	4	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	5	sources	source	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	6	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	7	8,9	8,9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	8	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	9	accessible	accessible	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	10	through	through	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	12	Internet	internet	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	14	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	15	created	create	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	16	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	17	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	18	database	database	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	19	based	base	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	20	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	22	cohort	cohort	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	23	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	24	medic-	medic-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	25	inal	inal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	26	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	27	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	28	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	29	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	30	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	31	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	32	during	during	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	33	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	34	period	period	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	35	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	36	January	January	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	37	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	38	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	39	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	40	date	date	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	41	when	when	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	42	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	43	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	44	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	45	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	46	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	47	created	create	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	48	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	49	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	50	December	December	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	51	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	35	52	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	2	specifically	specifically	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	3	examined	examine	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	6	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	7	Commis-	Commis-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	8	sion	sion	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	9	Register	Register	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	11	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	12	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	13	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	14	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	15	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	18	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	19	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	20	Assessment	Assessment	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	21	Reports	Reports	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	22	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	23	EPARs	epars	UH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	24	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	25	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	26	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	27	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	28	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	29	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	30	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	31	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	36	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	2	collected	collect	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	4	fol-	fol-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	5	lowing	low	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	6	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	8	year	year	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	10	approval	approval	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	12	name	name	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	15	med-	med-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	16	icinal	icinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	17	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	18	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	19	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	20	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	21	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	22	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	23	chemical	chemical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	24	entities	entity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	25	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	26	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	27	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	28	indication	indication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	29	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	30	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	31	seriousness	seriousness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	32	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	33	type	type	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	34	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	35	intervention	intervention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	36	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	37	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	38	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	39	variables	variable	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	40	when	when	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	41	appropriate	appropriate	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	42	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	43	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	44	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	45	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	46	mechanism	mechanism	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	47	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	48	biotechnological	biotechnological	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	49	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	50	biological	biological	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	51	pro-	pro-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	52	duct	duct	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	53	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	54	orphan	orphan	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	55	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	56	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	57	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	58	fixed	fix	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	59	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	60	dose	dose	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	61	combina-	combina-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	62	tions	tion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	63	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	64	drug	drug	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	65	associations	association	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	66	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	67	generics	generic	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	68	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	69	similar	similar	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	70	biological	biological	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	71	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	72	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	73	-	-	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	74	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	75	called	call	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	76	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	77	biosimilars	biosimilar	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	78	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	79	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	37	80	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	2	used	use	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	4	following	follow	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	5	definitions	definition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	6	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	7	Main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	8	indication	indication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	9	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	10	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	11	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	12	defined	define	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	13	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	15	first	first	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	16	approval	approval	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	17	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	18	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	19	given	give	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	20	drug	drug	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	22	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	23	later	later	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	24	approvals	approval	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	25	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	26	considered	consider	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	27	extensions	extension	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	38	28	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	1	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	2	seriousness	seriousness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	3	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	4	A	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	5	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	6	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	7	classified	classify	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	8	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	9	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	10	chronic	chronic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	11	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	12	serious	serious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	13	if	if	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	14	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	15	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	16	fatal	fatal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	17	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	18	requires	require	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	19	hospitalization	hospitalization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	20	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	21	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	22	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	23	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	24	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	25	threa-	threa-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	26	tening	tening	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	27	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	28	heavily	heavily	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	29	disabling	disable	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	30	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	31	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	32	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	33	myocardial	myocardial	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	34	infarction	infarction	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	35	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	36	dementia	dementia	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	37	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	38	pneumonia	pneumonia	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	39	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	40	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	41	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	42	nonserious	nonserious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	43	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	44	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	45	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	46	erectile	erectile	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	47	dysfunction	dysfunction	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	48	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	49	allergic	allergic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	50	rhinitis	rhinitis	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	51	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	52	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	53	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	54	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	55	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	56	risk	risk	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	57	factor	factor	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	58	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	59	serious	serious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	60	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	61	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	62	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	63	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	64	obesity	obesity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	65	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	66	hypertension	hypertension	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	67	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	68	anemia	anemia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	69	associated	associate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	70	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	71	chronic	chronic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	72	renal	renal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	73	failure	failure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	74	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	39	75	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	1	Type	type	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	3	intervention	intervention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	5	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	6	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	7	defined	define	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	8	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	9	prevention	prevention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	11	diagnosis	diagnosis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	13	treatment	treatment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	14	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	15	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	16	palliative	palliative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	17	care	care	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	18	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	19	rehabilitation	rehabilitation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	40	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	1	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	2	mechanism	mechanism	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	4	action	action	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	5	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	6	A	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	7	mechanism	mechanism	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	8	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	9	defined	define	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	10	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	11	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	12	if	if	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	14	primary	primary	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	15	pharmacodynamic	pharmacodynamic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	16	target	target	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	17	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	18	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	20	receptor	receptor	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	21	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	22	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	23	drug	drug	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	24	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	25	target	target	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	26	interaction	interaction	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	27	differed	differ	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	28	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	29	existing	exist	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	30	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	41	31	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	1	When	when	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	2	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	3	medicine	medicine	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	4	belonged	belong	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	5	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	6	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	7	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	8	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	9	class	class	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	10	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	12	mechanism	mechanism	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	14	action	action	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	15	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	16	unknown	unknown	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	17	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	18	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	19	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	20	classi-	classi-	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	21	fied	fie	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	22	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	23	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	42	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	1	Medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	2	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	3	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	4	which	which	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	5	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	6	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	7	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	8	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	9	withdrawn	withdraw	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	11	suspended	suspend	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	12	and/or	and/or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	13	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	14	renewed	renew	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	15	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	16	during	during	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	18	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	19	period	period	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	20	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	21	excluded	exclude	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	22	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	23	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	24	primary	primary	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	25	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	43	26	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	2	Pediatric	Pediatric	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	3	Regulation	Regulation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	4	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	5	Regulation	Regulation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	6	EC	EC	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	7	No	no	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	8	1901/	1901/	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	9	2006	2006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	10	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	11	came	come	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	12	into	into	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	13	place	place	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	14	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	15	improve	improve	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	16	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	17	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	18	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	19	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	20	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	22	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	23	without	without	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	24	subjecting	subject	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	25	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	26	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	27	unnecessary	unnecessary	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	28	trials	trial	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	29	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	30	delaying	delay	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	31	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	32	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	33	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	34	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	35	pro-	pro-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	36	ducts	duct	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	37	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	38	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	39	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	40	adults	adult	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	44	41	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	1	Since	since	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	2	then	then	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	4	all	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	5	patented	patent	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	6	medic-	medic-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	7	inal	inal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	8	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	9	submitted	submit	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	10	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	11	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	12	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	13	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	14	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	15	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	16	line	line	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	17	extension	extension	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	18	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	19	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	20	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	21	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	22	need	need	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	23	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	24	have	have	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	25	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	26	agreed	agree	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	27	drug	drug	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	28	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	29	plan	plan	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	31	namely	namely	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	32	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	33	Pediatric	Pediatric	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	34	Investigation	Investigation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	35	Plan	Plan	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	36	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	37	PIP	PIP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	38	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	45	39	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	1	Thus	thus	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	3	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	4	create	create	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	5	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	6	complementary	complementary	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	7	assessment	assessment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	9	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	10	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	11	activities	activity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	12	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	13	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	14	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	15	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	18	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	19	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	20	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	21	website	website	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	22	http://	http://	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	23	www.ema.europa.eu	www.ema.europa.eu	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	24	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	25	searched	search	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	26	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	27	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	28	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	29	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	30	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	31	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	32	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	33	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	34	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	46	35	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	9	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	12	http://www.ema.europa.eu	http://www.ema.europa.eu	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	13	http://www.ema.europa.eu	http://www.ema.europa.eu	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	14	respect	respect	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	15	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	16	opinions	opinion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	17	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	18	submitted	submit	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	19	PIPs	PIPs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	20	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	21	proxy	proxy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	22	variable	variable	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	23	used	use	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	24	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	25	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	26	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	27	output	output	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	28	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	47	29	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	2	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	3	included	include	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	4	decisions	decision	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	5	agreeing	agree	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	6	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	7	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	8	PIP	PIP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	10	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	11	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	12	without	without	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	13	partial	partial	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	14	waiver(s	waiver(s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	15	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	17	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	18	deferral(s	deferral(s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	19	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	48	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	1	These	these	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	2	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	3	provide	provide	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	4	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	5	about	about	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	6	what	what	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	7	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	8	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	9	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	10	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	12	pipeline	pipeline	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	13	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	14	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	15	help	help	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	16	illuminate	illuminate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	18	extent	extent	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	19	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	20	which	which	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	21	efforts	effort	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	22	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	23	focusing	focus	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	24	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	25	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	26	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	27	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	28	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	29	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	30	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	31	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	49	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	1	For	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	2	each	each	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	3	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	4	group	group	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	6	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	7	included	include	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	8	morbidity	morbidity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	10	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	11	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	12	according	accord	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	13	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	15	Global	Global	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	16	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	17	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	18	Dis-	Dis-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	19	ease	ease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	20	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	21	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	22	10,11	10,11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	23	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	50	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	1	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	2	project	project	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	3	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	4	conducted	conduct	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	5	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	7	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	8	Bank	Bank	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	11	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	12	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	13	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	14	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	15	WHO	WHO	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	16	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	17	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	18	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	19	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	20	Harvard	Harvard	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	21	School	School	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	22	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	23	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	24	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	25	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	26	quantify	quantify	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	27	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	28	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	29	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	30	disease	disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	31	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	32	injury	injury	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	33	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	34	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	35	populations	population	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	36	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	37	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	38	gather	gather	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	39	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	40	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	41	prevalence	prevalence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	42	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	43	incidence	incidence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	44	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	45	severity	severity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	46	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	47	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	48	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	49	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	50	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	51	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	52	more	more	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	53	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	54	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	55	causes	cause	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	56	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	57	4,10	4,10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	58	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	51	59	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	1	Burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	3	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	5	measured	measure	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	6	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	7	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	9	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	11	refers	refer	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	12	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	14	most	most	RBS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	15	recent	recent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	16	estimations	estimation	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	17	available	available	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	18	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	19	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	20	time	time	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	21	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	22	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	52	23	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	2	brief	brief	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	4	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	5	report	report	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	6	used	use	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	8	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	9	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	11	world	world	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	12	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	13	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	14	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	15	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	16	categories	category	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	17	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	18	defined	define	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	19	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	20	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	21	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	22	Bank	Bank	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	23	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	24	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	25	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	26	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	27	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	28	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	29	Member	Member	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	30	States	States	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	31	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	32	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	33	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	34	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	35	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	36	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	37	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	38	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	53	39	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	2	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	3	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	4	indications	indication	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	5	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	6	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	7	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	8	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	9	then	then	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	10	matched	match	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	11	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	13	categories	category	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	14	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	15	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	16	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	17	classification	classification	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	18	system	system	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	19	defined	define	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	20	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	22	Global	Global	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	23	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	24	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	25	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	26	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	27	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	28	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	29	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	54	30	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	1	Statistical	statistical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	2	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	3	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	4	established	establish	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	6	direction	direction	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	7	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	8	strength	strength	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	10	association	association	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	11	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	12	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	13	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	14	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	15	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	16	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	17	authorized	authorize	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	18	dur-	dur-	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	19	ing	e	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	20	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	21	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	22	period	period	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	23	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	24	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	25	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	26	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	27	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	55	28	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	2	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	3	subanalysis	subanalysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	4	regarding	regard	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	5	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	6	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	7	output	output	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	8	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	9	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	10	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	12	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	13	measured	measure	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	15	associations	association	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	16	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	18	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	19	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	20	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	21	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	22	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	23	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	24	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	25	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	26	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	27	age	age	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	28	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	29	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	30	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	31	age	age	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	32	group	group	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	33	reported	report	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	34	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	35	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	36	estimates	estimate	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	37	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	38	WHO	who	WP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	39	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	40	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	41	10,11	10,11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	42	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	43	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	44	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	45	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	46	decisions	decision	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	47	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	48	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	49	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	50	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	51	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	52	’s	’s	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	53	Pediatric	Pediatric	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	54	Commit-	Commit-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	55	tee	tee	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	56	agreeing	agree	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	57	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	58	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	59	PIP	PIP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	60	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	61	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	62	individual	individual	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	63	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	64	pro-	pro-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	65	duct	duct	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	56	66	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	1	Using	use	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	2	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	3	STATA	STATA	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	4	package	package	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	5	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	6	Version	version	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	7	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	9	StataCorp	StataCorp	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	10	LP	LP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	12	College	College	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	13	Station	Station	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	14	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	15	TX	TX	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	17	USA	USA	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	18	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	20	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	21	calculated	calculate	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	22	nonpara-	nonpara-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	23	metric	metric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	24	Spearman	Spearman	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	25	rank	rank	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	26	correlation	correlation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	27	coefficients	coefficient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	28	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	29	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	30	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	57	31	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	2	statistical	statistical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	3	significance	significance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	4	level	level	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	5	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	6	set	set	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	7	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	8	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	9	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	11	0.05	0.05	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	12	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	13	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	14	confidence	confidence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	15	level	level	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	17	95	95	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	18	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	19	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	58	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	1	Results	result	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	2	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	3	included	include	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	4	520	520	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	5	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	6	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	7	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	8	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	9	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	10	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	12	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	14	corresponding	correspond	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	15	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	16	338	338	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	17	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	18	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	19	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	20	Figure	figure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	21	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	22	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	59	23	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	1	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	2	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	3	describes	describe	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	4	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	5	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	6	char-	char-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	7	acteristics	acteristic	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	9	distribution	distribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	12	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	13	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	14	pro-	pro-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	15	ducts	duct	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	16	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	17	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	60	18	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	1	From	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	2	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	3	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	4	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	7	total	total	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	8	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	10	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	11	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	12	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	13	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	14	centralized	centralize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	15	proce-	proce-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	16	dure	dure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	17	increased	increase	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	61	18	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	1	Furthermore	furthermore	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	4	ratio	ratio	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	5	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	7	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	9	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	10	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	11	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	13	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	14	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	15	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	16	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	17	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	18	increased	increase	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	19	over	over	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	20	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	21	period	period	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	22	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	23	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	62	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	2	found	find	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	3	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	4	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	5	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	6	covered	cover	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	7	mainly	mainly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	8	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	10	preventive	preventive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	11	interventions	intervention	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	12	aimed	aim	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	13	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	14	serious	serious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	15	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	63	16	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	1	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	2	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	3	shows	show	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	4	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	5	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	6	data	data	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	7	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	8	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	9	output	output	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	11	phar-	phar-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	12	maceutical	maceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	13	development	development	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	14	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	15	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	16	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	17	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	18	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	19	cause	cause	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	20	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	21	region	region	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	64	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	2	indication	indication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	4	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	5	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	6	ingre-	ingre-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	7	dients	dient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	8	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	9	mainly	mainly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	10	malignant	malignant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	11	neoplasms	neoplasm	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	12	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	13	17.5	17.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	14	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	15	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	17	infec-	infec-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	18	tious	tious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	19	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	20	parasitic	parasitic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	21	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	22	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	23	16.6	16.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	24	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	25	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	26	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	27	blood	blood	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	28	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	29	endocrine	endocrine	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	30	disorders	disorder	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	31	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	32	12.7	12.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	33	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	34	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	35	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	36	neuropsychiatric	neuropsychiatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	37	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	38	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	39	10.9	10.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	40	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	41	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	42	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	43	cardiovascular	cardiovascular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	44	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	45	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	46	8.6	8.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	47	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	48	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	49	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	50	diabetes	diabetes	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	51	mellitus	mellitus	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	52	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	53	7.4	7.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	54	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	55	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	56	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	57	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	58	musculoskeletal	musculoskeletal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	59	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	60	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	61	7.1	7.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	62	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	63	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	65	64	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	2	general	general	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	4	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	5	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	6	association	association	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	7	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	8	found	find	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	9	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	10	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	11	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	12	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	14	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	15	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	16	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	17	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	18	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	19	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	20	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	21	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	22	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	23	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	24	0.619	0.619	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	26	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	27	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	28	0.005	0.005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	29	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	31	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	32	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	33	moderate	moderate	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	34	association	association	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	35	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	36	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	37	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	38	level	level	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	39	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	40	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	41	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	42	0.490	0.490	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	43	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	44	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	45	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	46	0.033	0.033	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	47	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	48	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	49	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	50	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	51	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	66	52	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	1	How-	How-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	2	ever	ever	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	4	these	these	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	5	associations	association	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	6	do	do	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	7	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	8	hide	hide	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	9	disproportionality	disproportionality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	10	rela-	rela-	XX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	11	tionships	tionship	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	12	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	14	various	various	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	15	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	16	categories	category	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	17	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	18	Figures	figure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	19	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	20	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	21	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	22	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	67	23	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	2	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	3	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	6	greatest	great	JJS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	7	disproportionality	disproportionality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	8	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	9	seen	see	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	10	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	11	infectious	infectious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	12	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	13	parasitic	parasitic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	14	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	16	blood	blood	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	18	endo-	endo-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	19	crine	crine	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	20	disorders	disorder	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	22	diabetes	diabetes	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	23	mellitus	mellitus	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	24	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	25	genitourinary	genitourinary	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	26	dis-	dis-	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	27	eases	ease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	28	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	29	all	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	30	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	31	them	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	32	overrepresented	overrepresente	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	33	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	34	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	35	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	36	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	37	they	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	38	generate	generate	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	39	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	68	40	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	1	Conversely	conversely	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	3	neuropsychiatric	neuropsychiatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	4	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	6	cardiovascular	cardiovascular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	7	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	9	sense	sense	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	10	organ	organ	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	11	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	13	respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	14	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	16	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	17	digestive	digestive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	18	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	19	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	20	underrepresented	underrepresented	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	21	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	22	Figure	Figure	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	23	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	24	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	69	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	1	Meanwhile	meanwhile	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	4	most	most	RBS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	5	neglected	neglected	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	6	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	7	worldwide	worldwide	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	8	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	9	based	base	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	10	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	11	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	13	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	14	mainly	mainly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	15	perinatal	perinatal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	16	condi-	condi-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	17	tions	tion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	18	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	19	respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	20	infections	infection	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	22	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	23	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	24	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	25	sense	sense	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	26	organs	organ	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	27	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	28	respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	29	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	31	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	32	digestive	digestive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	33	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	34	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	35	Figure	figure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	36	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	37	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	70	38	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	2	found	find	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	3	differences	difference	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	4	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	5	regions	region	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	6	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	7	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	9	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	10	better	well	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	11	associations	association	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	12	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	13	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	14	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	15	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	16	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	17	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	18	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	19	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	20	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	71	21	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	1	By	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	2	region	region	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	4	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	5	associations	association	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	6	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	7	stronger	strong	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	8	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	9	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	10	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	11	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	12	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	13	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	14	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	15	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	16	0.619	0.619	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	17	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	18	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	19	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	20	0.005	0.005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	21	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	22	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	23	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	24	mid-	mid-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	25	dle	dle	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	26	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	27	low	low	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	28	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	29	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	30	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	31	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	32	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	33	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	34	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	35	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	36	0.497	0.497	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	37	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	38	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	39	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	40	0.030	0.030	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	41	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	42	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	43	globally	globally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	44	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	45	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	46	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	47	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	48	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	49	0.490	0.490	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	50	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	51	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	52	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	53	0.033	0.033	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	54	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	55	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	56	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	57	similar	similar	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	58	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	59	those	those	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	60	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	61	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	62	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	63	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	64	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	65	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	66	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	67	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	68	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	69	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	70	0.606	0.606	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	71	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	72	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	73	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	74	0.006	0.006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	75	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	72	76	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	1	Differences	difference	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	2	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	3	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	4	found	find	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	5	within	within	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	7	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	9	577	577	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	10	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	11	authorisations	authorisation	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	12	granted	grant	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	13	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	14	356	356	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	15	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	16	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	17	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	18	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	19	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	20	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	21	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	22	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	23	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	24	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	25	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	26	522	522	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	27	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	28	authorisations	authorisation	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	29	granted	grant	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	30	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	31	339	339	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	32	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	33	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	34	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	35	selected	select	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	36	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	37	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	38	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	39	55	55	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	40	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	41	authorisations	authorisation	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	42	withdrawn	withdraw	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	43	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	44	suspended	suspend	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	45	and/or	and/or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	46	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	47	renewed	renew	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	48	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	49	45	45	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	50	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	51	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	52	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	53	excluded	exclude	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	54	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	55	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	56	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	57	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	58	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	59	authorisations	authorisation	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	60	granted	grant	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	61	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	62	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	63	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	64	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	65	no	no	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	66	specific	specific	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	67	indication	indication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	68	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	69	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	70	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	71	ingredient	ingredient	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	72	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	73	excluded	exclude	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	74	520	520	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	75	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	76	authorisations	authorisation	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	77	granted	grant	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	78	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	79	338	338	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	80	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	81	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	82	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	83	finally	finally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	84	included	include	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	85	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	86	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	87	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	88	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	89	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	90	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	91	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	92	Figure	Figure	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	93	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	94	Pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	95	output	output	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	96	selection	selection	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	73	97	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	1	Marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	2	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	3	granted	grant	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	4	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	5	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	6	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	7	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	8	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	9	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	10	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	11	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	12	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	14	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	15	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	16	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	74	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	75	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	75	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	75	3	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	75	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	75	5	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	75	6	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	75	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	9	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	12	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	14	associations	association	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	15	being	be	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	16	lower	low	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	17	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	18	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	19	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	20	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	21	recently	recently	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	22	joining	join	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	23	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	24	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	25	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	26	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	27	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	28	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	29	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	30	0.499	0.499	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	31	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	32	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	33	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	34	0.030	0.030	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	35	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	36	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	37	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	38	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	39	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	40	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	41	initially	initially	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	42	established	establish	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	43	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	44	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	45	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	46	r	r	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	47	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	48	0.603	0.603	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	49	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	50	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	51	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	52	0.006	0.006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	53	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	76	54	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	1	By	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	2	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	4	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	5	values	value	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	6	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	7	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	8	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	9	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	10	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	11	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	12	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	13	0.304	0.304	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	14	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	15	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	16	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	17	0.206	0.206	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	18	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	19	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	20	Poland	Poland	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	21	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	22	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	23	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	24	0.558	0.558	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	25	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	26	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	27	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	28	0.013	0.013	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	29	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	30	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	31	Luxembourg	Luxembourg	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	32	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	33	while	while	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	34	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	35	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	36	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	37	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	38	values	value	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	39	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	40	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	41	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	42	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	43	0.376	0.376	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	44	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	45	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	46	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	47	0.113	0.113	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	48	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	49	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	50	Finland	Finland	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	51	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	52	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	53	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	54	0.663	0.663	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	55	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	56	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	57	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	58	0.002	0.002	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	59	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	60	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	61	Portugal	Portugal	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	77	62	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	1	Additionally	additionally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	3	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	4	examined	examine	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	6	pharmaceutical	pharmaceutical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	7	devel-	devel-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	8	opment	opment	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	9	output	output	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	10	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	11	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	12	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	13	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	14	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	15	Tables	tables	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	16	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	18	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	19	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	78	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	2	identified	identify	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	3	103	103	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	4	PIPs	pip	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	5	agreed	agree	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	6	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	7	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	8	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	9	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	10	after	after	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	12	Pediatric	Pediatric	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	13	Regulation	Regulation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	14	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	15	introduced	introduce	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	79	16	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	1	No	no	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	2	evidence	evidence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	4	association	association	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	5	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	6	found	find	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	7	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	8	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	9	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	11	PIPs	pip	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	12	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	14	regional	regional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	15	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	17	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	18	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	19	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	20	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	21	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	22	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	23	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	24	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	25	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	26	r	r	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	27	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	28	0.079	0.079	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	29	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	30	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	31	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	32	0.779	0.779	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	33	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	34	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	35	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	36	r	r	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	37	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	38	0.404	0.404	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	39	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	40	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	41	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	42	0.135	0.135	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	43	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	80	44	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	1	Discussion	discussion	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	2	Our	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	3	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	4	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	6	period	period	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	7	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	9	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	10	uses	use	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	12	cohort	cohort	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	14	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	15	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	16	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	17	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	18	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	19	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	20	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	21	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	22	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	23	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	24	show	show	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	25	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	26	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	27	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	28	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	29	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	30	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	31	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	32	higher	high	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	33	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	34	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	35	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	36	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	37	others	other	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	81	38	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	2	three	three	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	3	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	4	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	5	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	6	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	7	terms	term	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	9	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	11	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	12	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	13	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	14	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	15	oncology	oncology	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	17	infectious	infectious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	18	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	19	parasitic	parasitic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	20	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	22	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	23	blood	blood	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	24	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	25	endocrine	endocrine	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	26	disor-	disor-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	27	ders	der	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	28	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	29	accounting	account	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	30	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	31	46.8	46.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	32	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	33	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	34	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	35	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	36	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	37	38.4	38.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	38	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	39	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	40	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	41	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	42	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	82	43	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	2	results	result	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	3	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	4	showed	show	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	5	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	6	moderate	moderate	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	7	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	8	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	9	association	association	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	10	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	12	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	14	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	15	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	17	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	18	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	19	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	20	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	22	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	23	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	24	categories	category	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	26	though	though	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	27	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	28	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	29	appear	appear	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	30	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	31	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	32	neglected	neglect	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	33	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	34	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	35	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	36	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	37	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	38	loss	loss	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	39	generated	generate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	40	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	41	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	42	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	43	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	44	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	45	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	46	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	47	case	case	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	48	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	49	neu-	neu-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	50	ropsychiatric	ropsychiatric	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	51	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	52	cardiovascular	cardiovascular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	53	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	54	respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	55	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	56	sense	sense	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	57	organ	organ	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	58	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	59	digestive	digestive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	60	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	61	perinatal	perinatal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	62	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	63	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	64	etc	etc	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	83	65	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	1	On	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	2	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	3	contrary	contrary	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	5	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	6	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	8	agreed	agree	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	9	PIPs	PIPs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	10	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	11	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	12	associated	associate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	13	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	15	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	17	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	18	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	19	deaths	death	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	20	among	among	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	21	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	22	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	23	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	24	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	84	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	1	Therefore	therefore	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	4	review	review	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	5	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	6	PIPs	PIPs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	7	suggested	suggest	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	8	again	again	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	9	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	10	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	11	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	12	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	13	were	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	14	more	more	RBR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	15	neglected	neglected	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	16	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	17	others	other	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	18	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	19	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	20	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	21	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	22	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	23	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	24	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	26	such	such	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	27	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	28	peri-	peri-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	29	natal	natal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	30	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	31	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	32	congenital	congenital	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	33	anomalies	anomaly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	34	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	35	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	36	neuropsy-	neuropsy-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	37	chiatric	chiatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	38	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	85	39	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	2	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	3	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	4	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	5	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	7	regulatory	regulatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	8	authority	authority	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	9	providing	provide	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	11	Member	Member	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	12	States	States	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	13	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	15	institu-	institu-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	16	tions	tion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	17	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	18	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	19	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	20	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	21	scientific	scientific	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	22	advice	advice	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	23	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	24	quality	quality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	26	safety	safety	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	27	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	28	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	29	efficacy	efficacy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	30	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	31	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	86	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	1	Medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	2	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	3	author-	author-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	4	ized	ize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	5	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	7	centralized	centralize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	8	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	9	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	10	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	11	automatically	automatically	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	12	marketed	market	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	13	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	14	all	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	15	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	16	Member	Member	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	17	States	States	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	87	18	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	1	Barbui	Barbui	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	2	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	3	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	4	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	5	12	12	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	6	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	7	highlighted	highlight	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	8	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	9	issues	issue	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	10	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	11	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	12	adversely	adversely	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	13	affect	affect	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	14	assessment	assessment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	15	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	16	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	17	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	18	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	19	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	20	dis-	dis-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	21	eases	ease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	88	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	1	First	first	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	4	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	5	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	6	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	7	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	8	mandatory	mandatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	9	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	10	all	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	11	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	12	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	13	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	14	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	15	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	18	different	different	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	19	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	20	procedures	procedure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	21	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	22	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	23	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	24	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	25	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	26	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	27	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	28	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	29	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	30	Main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	31	characteristics	characteristic	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	32	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	33	distribution	distribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	34	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	35	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	36	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	37	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	38	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	39	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	40	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	41	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	42	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	43	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	44	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	45	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	46	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	47	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	48	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	49	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	50	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	51	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	52	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	53	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	54	Period	Period	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	55	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	56	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	57	1999	1999	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	58	Period	Period	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	59	2000	2000	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	60	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	61	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	62	Period	Period	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	63	2005	2005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	64	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	65	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	66	Characteristics	Characteristics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	67	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	89	68	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	90	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	90	2	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	90	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	90	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	90	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	90	6	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	90	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	91	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	91	2	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	91	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	91	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	91	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	91	6	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	91	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	92	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	92	2	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	92	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	92	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	92	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	92	6	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	92	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	93	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	93	2	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	93	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	93	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	93	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	93	6	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	93	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	94	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	94	2	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	94	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	94	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	94	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	94	6	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	94	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	2	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	6	Total	Total	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	7	86	86	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	8	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	9	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	10	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	11	70	70	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	12	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	13	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	14	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	15	143	143	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	16	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	17	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	18	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	19	116	116	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	20	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	21	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	22	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	23	291	291	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	24	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	25	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	26	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	27	152	152	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	28	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	29	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	30	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	31	Type	type	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	32	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	33	intervention	intervention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	34	Prevention	Prevention	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	35	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	36	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	37	17.4	17.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	38	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	39	12	12	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	40	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	41	17.1	17.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	42	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	43	13	13	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	44	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	45	9.1	9.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	46	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	47	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	48	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	49	6.0	6.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	50	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	51	56	56	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	52	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	53	19.2	19.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	54	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	55	19	19	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	56	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	57	12.5	12.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	58	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	59	Diagnosis	diagnosis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	60	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	61	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	62	4.6	4.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	63	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	64	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	65	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	66	4.3	4.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	67	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	68	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	69	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	70	2.8	2.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	71	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	72	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	73	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	74	3.4	3.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	75	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	76	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	77	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	78	1.7	1.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	79	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	80	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	81	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	82	3.3	3.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	83	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	84	Treatment	Treatment	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	85	65	65	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	86	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	87	75.6	75.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	88	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	89	53	53	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	90	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	91	75.7	75.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	92	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	93	122	122	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	94	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	95	85.3	85.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	96	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	97	101	101	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	98	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	99	87.1	87.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	100	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	101	214	214	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	102	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	103	73.5	73.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	104	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	105	120	120	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	106	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	107	78.9	78.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	108	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	109	Palliative	palliative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	110	care/	care/	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	111	rehabilitation	rehabilitation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	112	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	113	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	114	2.3	2.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	115	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	116	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	117	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	118	2.9	2.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	119	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	120	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	121	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	122	2.8	2.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	123	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	124	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	125	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	126	3.4	3.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	127	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	128	16	16	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	129	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	130	5.5	5.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	131	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	132	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	133	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	134	5.3	5.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	135	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	136	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	137	seriousness	seriousness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	138	Serious	serious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	139	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	140	59	59	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	141	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	142	68.6	68.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	143	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	144	50	50	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	145	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	146	71.4	71.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	147	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	148	104	104	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	149	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	150	72.7	72.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	151	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	152	86	86	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	153	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	154	74.1	74.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	155	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	156	191	191	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	157	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	158	65.6	65.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	159	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	160	109	109	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	161	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	162	71.7	71.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	163	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	164	Nonserious	nonserious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	165	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	166	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	167	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	168	12.8	12.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	169	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	170	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	171	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	172	12.9	12.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	173	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	174	21	21	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	175	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	176	14.7	14.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	177	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	178	17	17	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	179	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	180	14.6	14.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	181	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	182	44	44	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	183	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	184	15.1	15.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	185	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	186	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	187	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	188	13.2	13.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	189	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	190	Risk	risk	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	191	factor	factor	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	192	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	193	serious	serious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	194	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	195	16	16	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	196	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	197	18.6	18.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	198	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	199	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	200	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	201	15.7	15.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	202	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	203	18	18	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	204	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	205	12.6	12.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	206	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	207	13	13	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	208	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	209	11.2	11.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	210	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	211	56	56	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	212	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	213	19.2	19.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	214	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	215	23	23	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	216	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	217	15.1	15.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	218	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	219	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	220	mechanism	mechanism	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	221	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	222	action	action	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	223	18	18	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	224	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	225	20.9	20.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	226	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	227	17	17	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	228	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	229	24.3	24.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	230	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	231	44	44	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	232	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	233	30.8	30.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	234	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	235	42	42	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	236	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	237	36.2	36.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	238	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	239	32	32	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	240	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	241	11.0	11.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	242	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	243	27	27	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	244	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	245	17.8	17.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	246	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	247	Fixed	fix	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	248	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	249	dose	dose	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	250	combinations	combination	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	251	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	252	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	253	7.0	7.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	254	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	255	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	256	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	257	5.7	5.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	258	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	259	13	13	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	260	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	261	9.1	9.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	262	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	263	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	264	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	265	6.9	6.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	266	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	267	37	37	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	268	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	269	12.7	12.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	270	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	271	18	18	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	272	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	273	11.8	11.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	274	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	275	Biotechnological/	biotechnological/	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	276	biological	biological	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	277	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	278	27	27	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	279	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	280	31.4	31.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	281	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	282	24	24	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	283	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	284	34.3	34.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	285	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	286	52	52	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	287	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	288	36.4	36.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	289	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	290	41	41	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	291	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	292	35.3	35.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	293	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	294	77	77	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	295	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	296	26.5	26.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	297	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	298	42	42	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	299	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	300	27.6	27.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	301	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	302	Orphan	Orphan	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	303	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	304	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	305	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	306	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	307	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	308	18	18	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	309	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	310	12.6	12.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	311	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	312	18	18	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	313	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	314	15.5	15.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	315	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	316	39	39	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	317	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	318	13.4	13.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	319	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	320	39	39	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	321	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	322	25.7	25.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	323	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	324	Generic	Generic	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	325	and/or	and/or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	326	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	327	biosimilar	biosimilar	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	328	"	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	329	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	330	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	331	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	332	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	333	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	334	69	69	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	335	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	336	23.7	23.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	337	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	338	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	339	Data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	340	do	do	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	341	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	342	sum	sum	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	343	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	344	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	345	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	346	because	because	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	347	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	348	rounding	round	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	349	errors	error	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	350	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	351	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	352	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	353	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	354	granted	grant	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	355	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	356	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	357	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	358	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	359	orphan	orphan	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	360	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	361	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	362	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	363	2001	2001	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	364	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	365	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	366	biosimilar	biosimilar	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	367	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	368	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	369	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	370	2006	2006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	371	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	372	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	373	generic	generic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	374	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	375	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	376	2007	2007	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	95	377	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	96	1	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	96	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	96	3	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	96	4	chemical	chemical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	96	5	entities	entity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	96	6	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	97	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	97	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	97	3	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	97	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	97	5	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	97	6	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	97	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	9	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	12	versus	versus	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	13	mutual	mutual	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	14	recognition	recognition	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	15	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	16	decentralized	decentralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	18	national	national	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	19	procedures	procedure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	20	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	21	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	22	result	result	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	23	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	24	heterogeneity	heterogeneity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	25	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	26	terms	term	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	27	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	28	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	29	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	30	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	31	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	32	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	98	33	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	1	Sec-	Sec-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	2	ond	ond	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	4	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	5	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	6	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	7	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	8	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	9	evaluated	evaluate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	10	without	without	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	11	needing	need	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	12	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	13	establish	establish	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	14	comparisons	comparison	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	15	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	16	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	17	treatments	treatment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	99	18	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	1	Therefore	therefore	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	3	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	4	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	5	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	6	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	7	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	8	marketed	market	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	9	if	if	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	10	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	11	shows	show	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	12	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	13	difference	difference	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	14	versus	versus	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	15	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	16	placebo	placebo	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	17	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	18	dummy	dummy	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	19	treatment	treatment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	20	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	22	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	23	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	24	cases	case	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	25	where	where	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	26	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	27	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	28	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	29	ethical	ethical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	31	demonstrating	demonstrate	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	32	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	33	noninferiority	noninferiority	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	34	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	35	versus	versus	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	36	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	37	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	38	comparator	comparator	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	39	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	40	per-	per-	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	41	mitted	mitte	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	100	42	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	1	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	2	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	3	cause	cause	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	4	uncertainty	uncertainty	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	5	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	7	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	8	role	role	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	10	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	11	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	12	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	14	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	15	suggested	suggest	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	16	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	17	recent	recent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	18	reviews	review	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	19	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	20	cancer	cancer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	21	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	22	13,14	13,14	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	23	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	25	cardiovascular	cardiovascular	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	26	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	27	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	28	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	29	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	30	antirheu-	antirheu-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	31	matic	matic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	32	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	33	16	16	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	34	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	35	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	36	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	37	central	central	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	38	nervous	nervous	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	39	system	system	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	40	treatments	treatment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	41	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	42	17	17	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	43	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	101	44	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	1	From	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	2	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	3	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	4	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	5	perspective	perspective	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	6	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	7	18	18	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	9	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	10	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	13	therapeu-	therapeu-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	14	tic	tic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	15	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	17	degree	degree	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	18	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	19	innovation	innovation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	20	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	21	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	22	pro-	pro-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	23	ducts	duct	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	24	could	could	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	25	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	26	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	27	considered	consider	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	28	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	29	referring	refer	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	30	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	31	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	32	added	add	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	33	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	34	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	35	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	36	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	37	available	available	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	38	options	option	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	102	39	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	1	Some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	4	items	item	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	5	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	6	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	7	highlighted	highlight	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	8	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	9	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	10	approach	approach	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	11	would	would	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	12	include	include	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	13	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	15	relative	relative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	16	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	17	incremental	incremental	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	18	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	19	compared	compare	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	20	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	22	available	available	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	23	alternatives	alternative	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	25	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	26	evaluation	evaluation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	27	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	28	real	real	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	29	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	30	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	31	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	32	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	33	comparative	comparative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	34	effectiveness	effectiveness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	35	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	36	safety	safety	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	37	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	38	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	39	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	40	even	even	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	41	its	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	42	incremental	incremental	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	43	costs	cost	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	44	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	45	efficiency	efficiency	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	46	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	47	cost	cost	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	48	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	49	effectiveness	effectiveness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	50	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	51	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	52	which	which	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	53	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	54	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	55	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	56	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	57	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	58	guiding	guide	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	59	pricing	pricing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	60	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	61	reimbursement	reimbursement	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	62	decisions	decision	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	63	following	follow	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	64	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	65	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	66	authorization	authorization	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	67	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	68	21,22	21,22	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	69	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	103	70	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	1	While	while	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	2	there	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	3	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	4	general	general	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	5	concern	concern	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	6	about	about	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	8	lack	lack	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	10	inno-	inno-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	11	vation	vation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	12	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	14	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	15	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	16	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	17	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	18	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	19	there	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	20	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	21	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	22	increased	increase	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	23	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	24	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	25	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	26	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	27	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	28	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	29	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	30	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	31	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	104	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	2	apparent	apparent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	3	increase	increase	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	4	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	5	cen-	cen-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	6	trally	trally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	7	authorized	authorize	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	8	generics	generic	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	10	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	11	biosimilars	biosimilar	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	13	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	14	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	15	fixed	fix	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	16	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	17	dose	dose	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	18	combinations	combination	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	19	observed	observe	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	20	over	over	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	22	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	23	period	period	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	24	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	25	have	have	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	26	contributed	contribute	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	27	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	28	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	29	situation	situation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	105	30	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	1	Furthermore	furthermore	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	3	these	these	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	4	results	result	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	5	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	6	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	7	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	8	sign	sign	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	11	failure	failure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	12	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	14	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	15	mar-	mar-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	16	ket	ket	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	17	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	18	anticipate	anticipate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	19	unmet	unmet	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	20	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	21	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	22	consumer	consumer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	23	demand	demand	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	106	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	107	1	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	107	2	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	107	3	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	107	4	involves	involve	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	107	5	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	107	6	limitations	limitation	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	107	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	1	First	first	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	4	assessment	assessment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	5	refers	refer	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	6	only	only	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	7	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	8	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	9	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	10	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	11	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	12	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	13	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	14	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	15	centralized	centralized	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	16	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	108	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	1	Though	though	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	2	there	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	3	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	4	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	5	alternative	alternative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	6	procedures	procedure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	7	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	8	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	9	assumed	assume	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	10	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	12	cohort	cohort	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	14	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	15	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	16	selected	select	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	17	here	here	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	18	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	19	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	20	con-	con-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	21	sidered	sidere	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	22	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	23	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	24	representative	representative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	25	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	26	current	current	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	27	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	28	innovation	innovation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	109	29	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	1	Second	second	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	3	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	4	measure	measure	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	5	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	6	develop-	develop-	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	7	ment	ment	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	8	output	output	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	10	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	11	used	use	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	12	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	14	primary	primary	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	15	analyses	analysis	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	16	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	17	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	18	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	19	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	20	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	21	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	22	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	23	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	24	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	25	ingredi-	ingredi-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	26	ents	ent	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	110	27	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	1	Despite	despite	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	2	being	be	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	3	significant	significant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	4	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	5	expressing	express	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	7	productivity	productivity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	9	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	10	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	11	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	12	activities	activity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	14	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	15	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	16	could	could	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	17	have	have	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	18	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	19	selected	select	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	20	instead	instead	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	21	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	22	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	23	Distribution	distribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	24	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	25	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	26	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	27	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	28	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	29	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	30	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	31	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	32	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	33	area	area	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	34	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	35	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	36	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	37	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	38	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	39	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	40	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	41	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	42	disease	disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	43	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	44	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	45	measured	measure	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	46	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	47	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	48	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	49	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	50	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	51	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	52	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	53	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	54	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	55	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	56	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	57	Medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	58	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	59	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	60	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	61	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	62	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	63	1995	1995	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	64	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	65	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	66	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	67	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	68	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	69	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	70	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	71	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	72	Marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	73	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	74	NCEs	NCEs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	75	Mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	76	per	per	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	77	106	106	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	78	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	79	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	80	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	81	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	82	per	per	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	83	106	106	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	84	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	85	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	86	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	87	Number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	88	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	89	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	90	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	91	Number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	92	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	93	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	94	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	95	Worldwide	Worldwide	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	96	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	97	Worldwide	Worldwide	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	98	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	99	Communicable	Communicable	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	100	diseases	disease	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	101	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	102	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	103	19.2	19.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	104	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	105	75	75	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	106	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	107	22.2	22.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	108	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	109	18.0	18.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	110	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	111	30.6	30.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	112	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	113	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	114	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	115	4.8	4.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	116	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	117	604.0	604.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	118	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	119	39.7	39.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	120	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	121	2.7	2.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	122	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	123	4.6	4.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	124	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	125	Infectious	infectious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	126	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	127	parasitic	parasitic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	128	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	129	68	68	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	130	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	131	13.1	13.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	132	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	133	56	56	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	134	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	135	16.6	16.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	136	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	137	9.5	9.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	138	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	139	16.2	16.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	140	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	141	.06	.06	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	142	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	143	1.3	1.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	144	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	145	302.1	302.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	146	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	147	19.8	19.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	148	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	149	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	150	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	151	1.6	1.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	152	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	153	Respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	154	infections	infection	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	155	19	19	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	156	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	157	3.6	3.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	158	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	159	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	160	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	161	2.4	2.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	162	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	163	4.3	4.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	164	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	165	7.2	7.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	166	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	167	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	168	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	169	3.1	3.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	170	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	171	97.8	97.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	172	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	173	6.4	6.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	174	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	175	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	176	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	177	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	178	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	179	Maternal	maternal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	180	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	181	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	182	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	183	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	184	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	185	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	186	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	187	2.7	2.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	188	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	189	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	190	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	191	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	192	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	193	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	194	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	195	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	196	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	197	38.9	38.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	198	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	199	2.6	2.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	200	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	201	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	202	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	203	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	204	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	205	Perinatal	perinatal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	206	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	207	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	208	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	209	0.4	0.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	210	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	211	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	212	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	213	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	214	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	215	3.2	3.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	216	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	217	5.4	5.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	218	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	219	.01	.01	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	220	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	221	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	222	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	223	126.4	126.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	224	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	225	8.3	8.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	226	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	227	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	228	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	229	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	230	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	231	Noncommunicable	noncommunicable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	232	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	233	419	419	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	234	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	235	80.6	80.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	236	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	237	262	262	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	238	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	239	77.5	77.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	240	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	241	35.0	35.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	242	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	243	59.6	59.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	244	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	245	4.0	4.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	246	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	247	89.9	89.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	248	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	249	731.6	731.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	250	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	251	48.0	48.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	252	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	253	51.1	51.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	254	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	255	87.4	87.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	256	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	257	Malignant	malignant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	258	neoplasms	neoplasm	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	259	73	73	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	260	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	261	14.0	14.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	262	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	263	59	59	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	264	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	265	17.5	17.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	266	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	267	7.4	7.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	268	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	269	12.6	12.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	270	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	271	1.2	1.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	272	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	273	27.0	27.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	274	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	275	77.8	77.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	276	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	277	5.1	5.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	278	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	279	9.7	9.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	280	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	281	16.6	16.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	282	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	283	Other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	284	neoplasms	neoplasm	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	285	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	286	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	287	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	288	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	289	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	290	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	291	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	292	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	293	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	294	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	295	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	296	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	297	.03	.03	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	298	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	299	0.8	0.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	300	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	301	1.9	1.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	302	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	303	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	304	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	305	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	306	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	307	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	308	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	309	Diabetes	diabetes	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	310	mellitus	mellitus	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	311	46	46	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	312	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	313	8.8	8.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	314	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	315	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	316	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	317	7.4	7.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	318	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	319	1.1	1.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	320	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	321	1.9	1.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	322	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	323	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	324	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	325	2.3	2.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	326	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	327	19.7	19.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	328	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	329	1.3	1.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	330	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	331	1.5	1.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	332	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	333	2.5	2.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	334	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	335	Blood	blood	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	336	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	337	endocrine	endocrine	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	338	disorders	disorder	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	339	59	59	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	340	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	341	11.3	11.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	342	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	343	43	43	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	344	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	345	12.7	12.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	346	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	347	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	348	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	349	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	350	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	351	.03	.03	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	352	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	353	0.7	0.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	354	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	355	10.4	10.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	356	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	357	0.7	0.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	358	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	359	0.7	0.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	360	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	361	1.3	1.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	362	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	363	Neuropsychiatric	neuropsychiatric	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	364	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	365	66	66	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	366	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	367	12.7	12.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	368	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	369	37	37	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	370	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	371	10.9	10.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	372	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	373	1.3	1.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	374	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	375	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	376	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	377	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	378	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	379	4.8	4.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	380	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	381	199.3	199.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	382	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	383	13.1	13.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	384	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	385	14.3	14.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	386	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	387	24.5	24.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	388	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	389	Sense	sense	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	390	organ	organ	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	391	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	392	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	393	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	394	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	395	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	396	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	397	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	398	3.0	3.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	399	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	400	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	401	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	402	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	403	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	404	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	405	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	406	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	407	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	408	86.9	86.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	409	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	410	5.7	5.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	411	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	412	4.4	4.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	413	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	414	7.5	7.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	415	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	416	Cardiovascular	Cardiovascular	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	417	diseases	disease	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	418	75	75	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	419	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	420	14.4	14.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	421	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	422	29	29	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	423	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	424	8.6	8.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	425	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	426	17.1	17.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	427	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	428	29.0	29.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	429	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	430	1.8	1.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	431	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	432	42.0	42.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	433	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	434	151.4	151.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	435	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	436	9.9	9.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	437	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	438	10.2	10.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	439	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	440	17.4	17.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	441	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	442	Respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	443	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	444	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	445	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	446	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	447	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	448	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	449	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	450	1.8	1.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	451	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	452	4.0	4.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	453	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	454	6.9	6.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	455	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	456	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	457	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	458	4.9	4.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	459	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	460	59.0	59.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	461	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	462	3.9	3.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	463	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	464	3.1	3.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	465	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	466	5.4	5.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	467	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	468	Digestive	Digestive	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	469	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	470	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	471	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	472	1.9	1.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	473	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	474	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	475	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	476	1.2	1.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	477	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	478	2.0	2.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	479	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	480	3.5	3.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	481	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	482	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	483	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	484	4.8	4.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	485	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	486	42.5	42.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	487	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	488	2.8	2.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	489	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	490	2.7	2.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	491	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	492	4.6	4.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	493	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	494	Genitourinary	Genitourinary	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	495	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	496	23	23	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	497	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	498	4.4	4.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	499	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	500	13	13	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	501	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	502	3.8	3.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	503	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	504	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	505	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	506	1.6	1.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	507	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	508	.07	.07	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	509	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	510	1.6	1.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	511	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	512	14.7	14.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	513	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	514	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	515	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	516	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	517	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	518	0.8	0.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	519	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	520	Skin	skin	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	521	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	522	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	523	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	524	1.3	1.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	525	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	526	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	527	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	528	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	529	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	530	.07	.07	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	531	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	532	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	533	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	534	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	535	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	536	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	537	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	538	4.0	4.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	539	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	540	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	541	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	542	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	543	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	544	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	545	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	546	Musculoskeletal	Musculoskeletal	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	547	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	548	31	31	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	549	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	550	6.0	6.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	551	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	552	24	24	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	553	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	554	7.1	7.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	555	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	556	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	557	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	558	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	559	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	560	.02	.02	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	561	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	562	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	563	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	564	30.9	30.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	565	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	566	2.0	2.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	567	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	568	2.6	2.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	569	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	570	4.4	4.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	571	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	572	Congenital	congenital	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	573	anomalies	anomaly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	574	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	575	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	576	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	577	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	578	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	579	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	580	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	581	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	582	0.4	0.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	583	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	584	0.7	0.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	585	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	586	.01	.01	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	587	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	588	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	589	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	590	25.3	25.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	591	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	592	1.7	1.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	593	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	594	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	595	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	596	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	597	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	598	Oral	oral	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	599	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	600	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	601	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	602	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	603	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	604	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	605	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	606	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	607	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	608	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	609	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	610	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	611	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	612	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	613	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	614	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	615	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	616	7.9	7.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	617	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	618	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	619	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	620	0.4	0.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	621	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	622	0.7	0.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	623	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	624	Unintentional	unintentional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	625	injuries	injury	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	626	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	627	poisoning	poisoning	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	628	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	629	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	630	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	631	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	632	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	633	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	634	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	635	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	636	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	637	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	638	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	639	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	640	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	641	.01	.01	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	642	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	643	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	644	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	645	7.5	7.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	646	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	647	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	648	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	649	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	650	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	651	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	652	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	653	Total	Total	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	654	520	520	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	655	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	656	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	657	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	658	338	338	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	659	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	660	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	661	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	662	58.8	58.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	663	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	664	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	665	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	666	4.4	4.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	667	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	668	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	669	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	670	1,523.2	1,523.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	671	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	672	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	673	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	674	58.4	58.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	675	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	676	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	677	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	678	Data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	679	do	do	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	680	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	681	sum	sum	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	682	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	683	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	684	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	685	because	because	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	686	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	687	rounding	round	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	688	errors	error	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	111	689	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	1	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	3	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	4	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	5	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	6	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	7	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	8	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	9	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	10	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	11	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	13	year	year	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	14	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	112	15	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	1	Burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	3	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	4	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	5	measured	measure	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	6	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	7	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	9	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	10	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	11	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	12	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	13	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	14	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	15	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	16	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	113	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	114	1	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	114	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	114	3	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	114	4	chemical	chemical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	114	5	entities	entity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	114	6	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	1	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	2	=	=	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	3	all	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	4	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	5	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	6	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	7	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	8	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	115	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	116	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	116	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	116	3	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	116	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	116	5	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	116	6	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	116	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	9	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	12	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	13	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	14	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	15	funding	funding	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	16	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	17	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	18	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	20	total	total	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	21	expendi-	expendi-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	22	tures	ture	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	23	per	per	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	24	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	25	area	area	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	26	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	27	per	per	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	28	DALY	DALY	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	29	lost	lose	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	31	etc	etc	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	33	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	117	34	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	2	number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	4	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	5	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	6	authorizations	authorization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	7	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	9	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	10	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	11	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	12	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	13	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	14	necessarily	necessarily	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	15	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	16	indication	indication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	17	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	18	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	19	interest	interest	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	20	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	21	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	22	given	give	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	23	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	24	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	25	they	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	26	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	27	represent	represent	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	28	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	29	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	30	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	31	structurally	structurally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	32	similar	similar	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	33	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	34	already	already	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	35	existing	exist	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	36	ones	one	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	37	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	38	only	only	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	39	minor	minor	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	40	pharmaceutical	pharmaceutical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	41	differences	difference	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	42	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	43	so	so	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	44	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	45	called	call	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	46	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	47	me-	me-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	48	too	too	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	49	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	50	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	51	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	118	52	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	2	addition	addition	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	4	broader	broad	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	5	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	6	status	status	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	7	measures	measure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	8	favorably	favorably	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	9	reflect	reflect	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	11	results	result	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	12	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	13	biomedical	biomedical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	14	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	15	investments	investment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	119	16	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	1	These	these	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	2	include	include	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	3	lower	low	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	4	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	5	lost	lose	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	7	lower	low	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	8	death	death	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	9	rates	rate	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	10	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	11	chronic	chronic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	12	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	14	longer	long	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	15	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	16	expectancy	expectancy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	18	improved	improved	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	19	quality	quality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	20	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	21	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	22	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	23	elderly	elderly	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	24	people	people	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	25	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	26	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	27	more	more	RBR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	28	effective	effective	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	29	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	30	earlier	early	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	31	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	32	detection	detection	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	33	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	34	23	23	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	35	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	120	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	1	Third	third	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	3	sometimes	sometimes	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	4	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	5	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	6	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	7	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	8	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	9	authorized	authorize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	10	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	11	more	more	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	12	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	13	one	one	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	14	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	15	indication	indication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	16	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	17	various	various	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	18	condi-	condi-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	19	tions	tion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	20	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	21	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	22	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	23	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	25	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	26	anticancer	anticancer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	27	agent	agent	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	28	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	29	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	30	treat-	treat-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	31	ment	ment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	32	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	33	solid	solid	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	34	tumors	tumor	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	35	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	36	hematological	hematological	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	37	malignancies	malignancy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	38	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	39	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	40	psychoanaleptic	psychoanaleptic	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	41	indicated	indicate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	42	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	43	depression	depression	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	44	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	45	diabetic	diabetic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	46	peripheral	peripheral	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	47	neuropathic	neuropathic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	48	pain	pain	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	49	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	50	etc	etc	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	51	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	52	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	121	53	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	1	For	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	2	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	3	purpose	purpose	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	4	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	5	our	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	6	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	7	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	8	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	9	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	10	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	11	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	12	imperfect	imperfect	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	13	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	15	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	16	indication	indication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	17	was	be	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	18	chosen	choose	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	122	19	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	1	However	however	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	3	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	4	think	think	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	5	using	use	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	7	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	8	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	9	groups	group	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	10	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	11	categories	category	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	12	instead	instead	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	14	subca-	subca-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	15	tegories	tegorie	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	16	while	while	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	17	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	18	using	use	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	19	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	20	comprehensive	comprehensive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	22	consistent	consistent	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	23	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	24	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	25	exclusive	exclusive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	26	classification	classification	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	27	system	system	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	28	enabled	enable	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	29	us	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	30	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	31	reduce	reduce	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	32	misclassification	misclassification	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	33	bias	bias	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	34	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	35	making	make	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	36	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	37	main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	38	findings	finding	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	39	robust	robust	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	123	40	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	2	approach	approach	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	4	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	5	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	6	has	have	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	7	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	8	used	use	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	9	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	10	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	11	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	13	such	such	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	14	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	15	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	16	services	service	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	17	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	18	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	19	24	24	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	20	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	21	26	26	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	22	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	124	23	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	1	Surpris-	Surpris-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	2	ingly	ingly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	4	little	little	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	5	attention	attention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	6	has	have	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	7	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	8	paid	pay	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	9	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	10	analyzing	analyze	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	11	dispro-	dispro-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	12	portionality	portionality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	13	among	among	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	14	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	15	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	16	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	18	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	19	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	20	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	21	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	22	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	23	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	125	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	2	par-	par-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	3	ties	tie	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	4	interested	interested	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	5	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	6	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	7	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	8	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	9	interventions	intervention	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	10	often	often	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	11	mention	mention	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	13	lack	lack	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	14	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	15	funds	fund	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	16	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	17	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	18	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	19	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	20	interven-	interven-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	21	tion	tion	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	22	without	without	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	23	considering	consider	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	24	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	25	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	26	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	27	implications	implication	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	126	28	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	1	A	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	2	previous	previous	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	3	report	report	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	4	concluded	conclude	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	5	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	6	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	7	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	8	does	do	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	9	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	10	reflect	reflect	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	12	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	13	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	14	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	15	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	17	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	18	less	less	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	19	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	20	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	21	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	22	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	23	resources	resource	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	24	invested	invest	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	25	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	26	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	27	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	28	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	29	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	30	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	31	contribute	contribute	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	32	90	90	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	33	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	34	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	35	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	36	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	37	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	38	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	39	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	40	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	41	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	42	known	know	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	43	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	44	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	45	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	46	10/90	10/90	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	47	gap	gap	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	48	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	49	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	50	27	27	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	51	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	127	52	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	1	It	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	2	has	have	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	3	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	4	argued	argue	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	5	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	7	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	8	industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	9	appears	appear	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	10	unwilling	unwilling	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	11	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	12	fund	fund	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	13	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	14	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	15	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	16	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	17	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	18	aimed	aim	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	19	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	20	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	21	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	22	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	23	middle	middle	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	24	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	25	low	low	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	26	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	27	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	28	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	29	because	because	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	30	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	31	pro-	pro-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	32	spects	spect	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	33	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	34	financial	financial	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	35	gain	gain	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	36	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	37	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	38	industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	39	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	40	limited	limit	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	41	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	42	28	28	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	43	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	128	44	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	1	Our	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	2	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	3	provides	provide	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	4	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	5	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	6	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	7	matter	matter	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	129	8	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	1	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	2	found	find	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	3	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	4	nearly	nearly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	5	80	80	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	6	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	7	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	8	262/338	262/338	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	9	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	11	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	12	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	13	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	14	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	15	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	16	aimed	aim	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	17	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	18	less	less	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	19	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	20	50	50	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	21	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	22	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	23	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	24	losses	loss	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	25	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	26	expressed	express	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	27	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	28	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	29	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	30	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	31	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	32	world	world	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	33	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	34	accounting	account	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	35	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	36	90	90	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	37	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	38	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	39	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	40	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	41	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	42	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	43	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	44	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	45	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	46	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	47	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	48	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	49	case	case	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	50	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	51	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	52	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	130	53	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	1	Although	although	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	2	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	3	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	4	appear	appear	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	5	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	6	indicate	indicate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	7	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	8	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	9	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	10	10/90	10/90	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	11	gap	gap	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	12	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	13	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	14	decreasing	decrease	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	16	there	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	17	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	18	still	still	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	19	neglected	neglect	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	20	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	21	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	22	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	131	23	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	1	It	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	2	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	3	noteworthy	noteworthy	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	4	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	5	mention	mention	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	6	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	8	availability	availability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	10	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	11	depends	depend	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	12	partially	partially	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	13	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	15	state	state	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	17	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	18	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	19	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	20	particular	particular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	21	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	132	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	1	Indeed	indeed	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	3	some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	4	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	5	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	6	require	require	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	7	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	8	more	more	RBR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	9	significant	significant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	10	investment	investment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	11	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	12	resources	resource	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	13	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	14	develop	develop	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	15	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	16	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	133	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	2	lack	lack	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	4	novel	novel	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	5	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	6	pro-	pro-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	7	ducts	duct	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	8	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	9	specific	specific	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	10	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	11	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	12	also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	13	indicate	indicate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	14	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	15	there	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	16	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	17	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	18	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	19	patent	patent	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	20	protection	protection	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	21	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	22	marketing	market	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	23	exclusiv-	exclusiv-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	24	ity	ity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	25	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	26	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	27	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	28	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	29	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	30	market	market	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	31	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	32	saturated	saturate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	33	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	34	those	those	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	35	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	134	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	1	Therefore	therefore	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	4	financial	financial	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	5	rewards	reward	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	6	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	8	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	9	industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	10	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	11	develop	develop	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	12	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	14	rele-	rele-	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	15	vant	vant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	16	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	17	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	18	may	may	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	19	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	20	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	21	profitable	profitable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	22	enough	enough	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	23	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	24	assume	assume	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	25	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	26	risky	risky	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	27	nature	nature	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	28	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	29	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	30	investments	investment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	135	31	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	1	On	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	2	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	3	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	4	hand	hand	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	7	granting	granting	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	9	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	10	approval	approval	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	11	does	do	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	12	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	13	necessarily	necessarily	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	14	translate	translate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	15	into	into	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	16	improved	improved	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	17	availability	availability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	18	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	19	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	136	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	2	fact	fact	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	4	access	access	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	5	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	6	medicines	medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	7	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	8	far	far	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	9	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	10	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	11	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	12	Associations	Associations	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	14	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	15	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	16	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	17	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	18	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	19	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	20	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	21	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	22	disease	disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	23	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	24	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	25	measured	measure	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	26	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	27	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	28	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	29	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	30	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	31	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	32	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	33	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	34	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	35	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	36	region	region	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	37	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	38	country	country	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	39	Mortality	Mortality	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	40	DALYs	DALYs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	41	Coefficient	Coefficient	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	42	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	43	p-	p-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	44	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	45	Coefficient	Coefficient	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	46	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	47	p-	p-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	48	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	49	Worldwide	Worldwide	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	50	.417	.417	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	51	.076	.076	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	52	.490	.490	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	53	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	54	.033	.033	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	55	High	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	56	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	57	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	58	.485	.485	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	59	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	60	.035	.035	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	61	.606	.606	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	62	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	63	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	64	.006	.006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	65	Low-	Low-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	66	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	67	middle-	middle-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	68	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	69	.413	.413	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	70	.079	.079	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	71	.497	.497	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	72	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	73	.030	.030	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	74	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	75	.449	.449	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	76	.054	.054	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	77	.619	.619	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	78	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	79	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	80	.005	.005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	81	EU-15	eu-15	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	82	.492	.492	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	83	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	84	.032	.032	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	85	.603	.603	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	86	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	87	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	88	.006	.006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	89	Austria	Austria	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	90	.491	.491	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	91	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	92	.033	.033	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	93	.619	.619	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	94	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	95	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	96	.005	.005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	97	Belgium	Belgium	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	98	.554	.554	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	99	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	100	.014	.014	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	101	.637	.637	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	102	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	103	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	104	.003	.003	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	105	Denmark	denmark	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	106	.441	.441	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	107	.059	.059	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	108	.562	.562	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	109	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	110	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	111	.012	.012	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	112	Finland	finland	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	113	.334	.334	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	114	.162	.162	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	115	.376	.376	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	116	.113	.113	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	117	France	France	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	118	.555	.555	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	119	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	120	.014	.014	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	121	.612	.612	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	122	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	123	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	124	.005	.005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	125	Germany	Germany	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	126	.455	.455	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	127	.050	.050	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	128	.657	.657	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	129	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	130	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	131	.002	.002	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	132	Greece	Greece	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	133	.495	.495	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	134	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	135	.031	.031	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	136	.610	.610	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	137	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	138	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	139	.006	.006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	140	Ireland	Ireland	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	141	.484	.484	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	142	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	143	.036	.036	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	144	.504	.504	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	145	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	146	.028	.028	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	147	Italy	Italy	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	148	.455	.455	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	149	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	150	.558	.558	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	151	.641	.641	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	152	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	153	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	154	.003	.003	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	155	Luxembourg	luxembourg	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	156	.558	.558	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	157	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	158	.013	.013	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	159	.585	.585	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	160	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	161	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	162	.008	.008	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	163	Netherlands	Netherlands	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	164	.483	.483	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	165	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	166	.036	.036	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	167	.534	.534	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	168	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	169	.018	.018	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	170	Portugal	Portugal	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	171	.476	.476	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	172	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	173	.039	.039	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	174	.663	.663	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	175	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	176	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	177	.002	.002	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	178	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	179	.518	.518	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	180	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	181	.023	.023	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	182	.620	.620	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	183	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	184	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	185	.005	.005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	186	Sweden	Sweden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	187	.452	.452	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	188	.052	.052	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	189	.550	.550	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	190	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	191	.015	.015	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	192	United	United	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	193	Kingdom	Kingdom	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	194	.476	.476	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	195	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	196	.039	.039	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	197	.564	.564	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	198	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	199	.012	.012	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	200	EU-10	EU-10	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	201	.304	.304	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	202	.206	.206	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	203	.499	.499	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	204	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	205	.030	.030	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	206	Cyprus	Cyprus	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	207	.425	.425	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	208	.070	.070	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	209	.627	.627	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	210	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	211	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	212	.004	.004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	213	Czech	Czech	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	214	Republic	Republic	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	215	.337	.337	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	216	.159	.159	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	217	.487	.487	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	218	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	219	.035	.035	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	220	Estonia	Estonia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	221	.316	.316	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	222	.188	.188	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	223	.475	.475	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	224	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	225	.040	.040	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	226	Hungary	Hungary	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	227	.373	.373	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	228	.116	.116	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	229	.501	.501	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	230	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	231	.029	.029	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	232	Latvia	Latvia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	233	.248	.248	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	234	.306	.306	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	235	.513	.513	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	236	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	237	.025	.025	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	238	Lithuania	Lithuania	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	239	.207	.207	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	240	.394	.394	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	241	.404	.404	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	242	.086	.086	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	243	Malta	Malta	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	244	.328	.328	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	245	.171	.171	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	246	.578	.578	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	247	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	248	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	249	.010	.010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	250	Poland	Poland	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	251	.304	.304	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	252	.206	.206	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	253	.571	.571	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	254	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	255	.011	.011	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	256	Slovakia	Slovakia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	257	.326	.326	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	258	.173	.173	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	259	.547	.547	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	260	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	261	.015	.015	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	262	Slovenia	Slovenia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	263	.344	.344	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	264	.149	.149	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	265	.492	.492	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	266	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	267	.032	.032	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	268	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	269	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	270	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	271	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	272	<	<	XX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	273	.05	.05	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	274	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	275	bilateral	bilateral	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	276	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	277	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	278	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	279	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	280	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	281	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	282	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	283	<	<	XX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	284	0.01	0.01	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	285	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	286	bilateral	bilateral	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	287	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	137	288	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	1	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	2	=	=	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	3	all	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	4	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	5	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	6	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	7	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	8	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	138	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	139	1	EU-15	EU-15	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	139	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	139	3	established	establish	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	139	4	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	139	5	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	139	6	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	1	EU-10	EU-10	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	2	=	=	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	3	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	4	newly	newly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	5	joined	join	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	6	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	7	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	140	8	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	1	Data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	2	represent	represent	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	3	Spearman	Spearman	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	4	’s	’s	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	5	rank	rank	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	6	correlation	correlation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	7	coefficients	coefficient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	8	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	9	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	10	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	141	11	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	1	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	3	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	4	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	5	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	6	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	7	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	142	8	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	143	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	143	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	143	3	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	143	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	143	5	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	143	6	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	143	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	9	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	12	being	be	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	13	globally	globally	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	14	harmonized	harmonize	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	15	because	because	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	16	price	price	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	18	reimburse-	reimburse-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	19	ment	ment	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	20	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	21	still	still	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	22	matters	matter	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	23	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	24	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	25	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	26	consider	consider	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	27	accord-	accord-	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	28	ing	e	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	29	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	30	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	31	government	government	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	32	policies	policy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	33	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	34	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	35	resources	resource	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	36	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	37	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	38	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	39	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	40	systems	system	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	41	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	42	14	14	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	43	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	144	44	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	1	This	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	2	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	3	particularly	particularly	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	4	important	important	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	5	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	6	middle	middle	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	7	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	8	low	low	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	9	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	10	income	income	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	11	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	13	where	where	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	14	there	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	15	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	16	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	17	access	access	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	18	problem	problem	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	19	either	either	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	20	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	21	issues	issue	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	22	linked	link	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	23	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	24	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	25	cost	cost	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	26	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	27	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	28	acquisition	acquisition	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	29	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	30	defective	defective	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	31	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	32	structures	structure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	33	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	34	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	35	underdiagnosis	underdiagnosis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	145	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	1	For	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	2	example	example	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	4	about	about	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	5	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	6	million	million	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	7	people	people	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	8	die	die	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	9	every	every	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	10	year	year	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	11	worldwide	worldwide	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	12	because	because	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	14	communicable	communicable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	15	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	16	such	such	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	17	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	18	diarrheal	diarrheal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	19	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	20	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	21	HIV	HIV	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	22	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	23	AIDS	AIDS	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	25	tuberculosis	tuberculosis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	26	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	27	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	28	malaria	malaria	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	29	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	30	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	31	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	32	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	33	even	even	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	34	though	though	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	35	these	these	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	36	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	37	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	38	treatable	treatable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	39	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	40	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	41	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	42	least	least	JJS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	43	preventable	preventable	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	44	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	45	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	46	current	current	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	47	interventions	intervention	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	146	48	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	2	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	3	case	case	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	4	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	5	noncommunicable	noncommunicable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	6	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	7	such	such	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	8	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	9	diabetes	diabetes	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	10	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	11	other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	12	cardiovascular	cardiovascular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	13	risk	risk	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	14	factors	factor	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	15	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	16	e.g.	e.g.	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	17	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	18	hypertension	hypertension	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	20	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	21	f	f	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	22	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	23	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	24	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	25	io	io	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	26	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	27	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	28	a	a	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	29	n	n	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	30	d	d	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	31	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	32	a	a	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	33	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	34	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	35	s	s	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	36	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	37	ic	ic	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	38	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	39	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	40	Ma	Ma	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	41	lig	lig	UH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	42	n	n	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	43	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	44	n	n	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	45	t	t	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	46	n	n	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	47	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	48	o	o	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	49	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	50	la	la	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	51	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	52	m	m	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	53	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	54	Dia	Dia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	55	b	b	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	56	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	57	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	58	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	59	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	60	m	m	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	61	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	62	llit	llit	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	63	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	64	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	65	En	En	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	66	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	67	o	o	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	68	c	c	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	69	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	70	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	71	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	72	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	73	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	74	o	o	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	75	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	76	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	77	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	78	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	79	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	80	Ne	Ne	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	81	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	82	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	83	o	o	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	84	p	p	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	85	s	s	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	86	yc	yc	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	87	h	h	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	88	ia	ia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	89	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	90	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	91	ic	ic	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	92	Se	Se	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	93	n	n	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	94	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	95	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	96	o	o	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	97	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	98	g	g	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	99	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	100	n	n	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	101	C	C	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	102	a	a	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	103	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	104	d	d	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	105	io	io	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	106	v	v	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	107	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	108	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	109	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	110	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	111	la	la	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	112	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	113	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	114	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	115	Ge	Ge	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	116	n	n	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	117	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	118	o	o	XX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	119	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	120	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	121	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	122	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	123	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	124	y	y	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	125	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	126	Mu	Mu	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	127	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	128	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	129	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	130	lo	lo	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	131	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	132	k	k	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	133	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	134	le	le	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	135	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	136	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	137	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	138	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	139	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	140	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	141	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	142	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	143	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	144	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	145	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	146	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	147	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	148	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	149	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	150	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	151	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	152	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	153	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	154	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	155	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	156	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	157	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	158	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	159	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	160	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	161	Di	Di	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	162	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	163	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	164	b	b	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	165	i	i	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	166	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	167	i	i	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	168	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	169	y	y	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	170	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	171	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	172	j	j	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	173	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	174	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	175	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	176	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	177	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	178	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	179	i	i	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	180	f	f	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	181	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	182	ye	ye	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	183	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	184	rs	rs	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	185	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	186	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	187	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	188	P	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	189	h	h	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	190	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	191	rm	rm	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	192	a	a	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	193	c	c	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	194	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	195	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	196	ti	ti	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	197	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	198	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	199	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	200	o	o	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	201	u	u	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	202	tp	tp	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	203	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	204	t	t	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	205	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	206	N	N	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	207	C	c	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	208	E	e	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	209	s	s	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	210	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	211	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	212	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	213	Figure	figure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	214	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	215	Bubble	bubble	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	216	plot	plot	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	217	representing	representing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	218	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	219	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	220	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	221	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	222	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	223	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	224	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	225	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	226	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	227	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	228	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	229	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	230	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	231	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	232	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	233	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	147	234	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	2	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	4	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	5	bubbles	bubble	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	6	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	7	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	8	’	’	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	9	weighted	weighted	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	10	contribution	contribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	11	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	12	each	each	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	13	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	14	condition(s	condition(s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	15	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	16	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	18	total	total	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	19	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	20	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	21	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	148	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	1	1	1	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	2	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	3	Other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	4	neoplasms	neoplasm	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	5	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	6	2	2	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	8	Unintentional	unintentional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	9	injuries	injury	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	10	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	11	poisoning	poisoning	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	13	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	14	3	3	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	15	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	16	Congenital	congenital	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	17	anomalies	anomaly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	18	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	19	4	4	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	20	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	21	Digestive	digestive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	22	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	23	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	24	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	25	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	26	Respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	27	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	28	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	29	6	6	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	30	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	31	Skin	skin	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	32	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	33	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	34	7	7	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	35	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	36	Respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	37	infections	infection	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	38	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	39	8	8	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	40	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	41	Maternal	maternal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	42	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	43	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	44	9	9	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	45	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	46	Perinatal	perinatal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	47	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	149	48	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	1	Inf	Inf	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	2	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	3	c	c	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	4	t	t	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	5	io	io	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	6	us	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	7	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	8	n	n	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	9	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	10	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	11	a	a	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	12	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	13	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	14	s	s	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	15	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	16	ic	ic	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	17	Re	Re	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	18	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	19	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	20	ir	ir	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	21	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	22	t	t	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	23	o	o	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	24	ry	ry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	25	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	26	f	f	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	27	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	28	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	29	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	30	io	io	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	31	n	n	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	32	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	33	Ma	Ma	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	34	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	35	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	36	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	37	n	n	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	38	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	39	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	40	Pe	Pe	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	41	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	42	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	43	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	44	t	t	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	45	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	46	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	47	Ma	Ma	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	48	lig	lig	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	49	n	n	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	50	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	51	n	n	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	52	t	t	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	53	n	n	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	54	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	55	o	o	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	56	p	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	57	la	la	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	58	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	59	m	m	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	60	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	61	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	62	Dia	Dia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	63	b	b	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	64	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	65	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	66	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	67	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	68	m	m	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	69	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	70	llit	llit	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	71	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	72	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	73	En	En	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	74	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	75	o	o	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	76	c	c	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	77	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	78	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	79	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	80	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	81	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	82	o	o	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	83	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	84	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	85	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	86	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	87	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	88	Ne	Ne	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	89	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	90	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	91	o	o	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	92	p	p	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	93	s	s	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	94	yc	yc	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	95	h	h	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	96	ia	ia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	97	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	98	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	99	ic	ic	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	100	Se	Se	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	101	n	n	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	102	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	103	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	104	o	o	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	105	r	r	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	106	g	g	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	107	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	108	n	n	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	109	Ca	Ca	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	110	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	111	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	112	io	io	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	113	va	va	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	114	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	115	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	116	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	117	la	la	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	118	r	r	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	119	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	120	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	121	Ge	Ge	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	122	n	n	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	123	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	124	o	o	XX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	125	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	126	rin	rin	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	127	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	128	ry	ry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	129	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	130	Mu	Mu	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	131	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	132	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	133	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	134	lo	lo	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	135	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	136	k	k	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	137	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	138	le	le	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	139	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	140	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	141	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	142	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	143	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	144	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	145	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	146	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	147	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	148	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	149	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	150	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	151	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	152	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	153	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	154	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	155	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	156	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	157	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	158	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	159	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	160	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	161	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	162	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	163	0	0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	164	D	d	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	165	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	166	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	167	b	b	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	168	ilit	ilit	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	169	y	y	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	170	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	171	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	172	ju	ju	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	173	s	s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	174	t	t	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	175	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	176	d	d	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	177	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	178	ye	ye	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	179	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	180	rs	rs	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	181	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	182	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	183	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	184	P	p	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	185	h	h	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	186	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	187	rm	rm	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	188	a	a	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	189	c	c	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	190	e	e	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	191	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	192	ti	ti	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	193	c	c	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	194	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	195	l	l	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	196	o	o	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	197	u	u	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	198	tp	tp	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	199	u	u	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	200	t	t	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	201	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	202	N	N	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	203	C	c	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	204	E	e	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	205	s	s	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	206	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	207	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	208	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	209	Figure	figure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	210	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	211	Bubble	bubble	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	212	plot	plot	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	213	representing	representing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	214	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	215	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	216	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	217	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	218	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	219	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	220	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	221	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	222	worldwide	worldwide	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	223	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	224	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	225	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	226	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	227	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	228	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	150	229	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	2	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	4	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	5	bubbles	bubble	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	6	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	7	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	8	’	’	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	9	weighted	weighted	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	10	contribution	contribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	11	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	12	each	each	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	13	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	14	condition(s	condition(s	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	15	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	16	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	17	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	18	total	total	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	19	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	20	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	21	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	151	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	1	1	1	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	2	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	3	Other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	4	neoplasms	neoplasm	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	5	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	6	2	2	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	8	Unintentional	unintentional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	9	injuries	injury	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	10	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	11	poisoning	poisoning	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	13	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	14	3	3	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	15	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	16	Congenital	congenital	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	17	anomalies	anomaly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	18	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	19	4	4	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	20	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	21	Digestive	digestive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	22	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	23	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	24	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	25	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	26	Respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	27	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	28	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	29	6	6	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	30	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	31	Skin	skin	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	32	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	152	33	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	153	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	153	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	153	3	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	153	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	153	5	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	153	6	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	153	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	9	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	12	obesity	obesity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	14	smoking	smoking	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	16	etc	etc	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	154	18	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	1	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	2	which	which	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	3	interventions	intervention	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	4	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	5	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	6	only	only	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	7	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	8	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	9	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	10	available	available	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	12	many	many	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	13	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	14	systems	system	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	15	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	16	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	17	meet	meet	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	18	population	population	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	19	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	20	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	22	poorest	poor	JJS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	23	communities	community	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	155	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	1	Chronic	chronic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	2	noncommunicable	noncommunicable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	3	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	4	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	5	developing	develop	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	6	coun-	coun-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	7	tries	try	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	8	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	9	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	10	just	just	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	11	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	12	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	14	elderly	elderly	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	16	since	since	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	17	cardiovas-	cardiovas-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	18	cular	cular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	19	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	20	account	account	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	21	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	22	as	as	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	23	many	many	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	24	deaths	death	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	25	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	26	young	young	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	27	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	28	middle	middle	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	29	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	30	aged	aged	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	31	adults	adult	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	32	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	33	HIV	HIV	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	34	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	35	AIDS	AIDS	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	156	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	1	Also	also	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	3	chronic	chronic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	4	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	5	affect	affect	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	6	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	7	much	much	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	8	higher	high	JJR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	9	proportion	proportion	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	11	people	people	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	12	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	13	developing	develop	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	14	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	15	during	during	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	16	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	17	prime	prime	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	18	working	working	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	19	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	20	than	than	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	21	they	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	22	do	do	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	23	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	24	developed	develop	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	25	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	26	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	27	29	29	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	28	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	157	29	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	1	There	there	EX
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	2	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	3	several	several	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	4	challenges	challenge	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	5	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	6	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	7	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	8	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	9	require	require	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	10	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	11	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	12	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	13	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	14	regional	regional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	15	strategic	strategic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	16	approach	approach	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	17	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	18	including	include	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	19	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	20	availability	availability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	21	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	22	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	23	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	24	current	current	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	25	unmet	unmet	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	26	medical	medical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	27	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	28	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	29	among	among	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	30	others	other	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	31	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	32	30,31	30,31	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	33	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	158	34	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	1	Some	some	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	2	investigators	investigator	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	3	have	have	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	4	suggested	suggest	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	5	incentives	incentive	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	6	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	7	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	8	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	9	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	10	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	11	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	12	effective	effective	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	13	against	against	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	14	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	15	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	16	high	high	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	17	societal	societal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	18	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	19	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	20	gravity	gravity	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	21	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	22	populations	population	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	159	23	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	1	These	these	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	2	include	include	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	3	incentives	incentive	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	4	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	5	novelty	novelty	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	7	comparative	comparative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	8	effectiveness	effectiveness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	10	safety	safety	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	12	extended	extend	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	13	patent	patent	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	14	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	17	pricing	price	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	18	enhance-	enhance-	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	19	ments	ment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	20	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	21	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	22	aimed	aim	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	23	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	24	particular	particular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	25	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	26	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	27	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	160	28	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	1	Such	such	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	2	incentives	incentive	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	3	have	have	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	4	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	5	used	use	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	6	successfully	successfully	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	7	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	8	vaccines	vaccine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	10	low	low	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	11	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	12	prevalence	prevalence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	13	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	14	orphan	orphan	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	15	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	16	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	17	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	18	29	29	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	19	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	161	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	1	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	2	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	3	Main	main	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	4	characteristics	characteristic	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	5	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	7	Pediatric	Pediatric	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	8	Investigation	Investigation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	9	Plans	Plans	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	10	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	11	PIPs	PIPs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	13	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	14	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	15	active	active	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	16	ingredients	ingredient	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	17	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	18	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	19	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	20	Characteristics	Characteristics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	21	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	162	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	163	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	163	2	PIPs	PIPs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	163	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	163	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	163	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	163	6	Num	Num	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	163	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	1	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	2	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	3	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	4	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	5	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	6	Total	Total	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	7	103	103	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	8	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	9	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	10	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	11	95	95	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	12	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	13	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	14	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	15	Type	type	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	17	intervention	intervention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	18	Prevention	Prevention	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	19	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	20	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	21	10.7	10.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	22	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	23	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	24	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	25	8.4	8.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	26	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	27	Diagnosis	Diagnosis	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	28	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	29	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	30	Treatment	Treatment	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	31	85	85	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	32	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	33	82.5	82.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	34	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	35	80	80	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	36	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	37	84.2	84.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	38	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	39	Palliative	palliative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	40	care	care	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	41	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	42	rehabilitation	rehabilitation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	43	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	44	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	45	6.8	6.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	46	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	47	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	48	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	49	7.4	7.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	50	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	51	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	52	seriousness	seriousness	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	53	Serious	serious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	54	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	55	73	73	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	56	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	57	70.1	70.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	58	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	59	66	66	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	60	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	61	69.5	69.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	62	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	63	Nonserious	nonserious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	64	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	65	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	66	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	67	19.4	19.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	68	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	69	19	19	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	70	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	71	20.0	20.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	72	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	73	Risk	risk	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	74	factor	factor	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	75	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	76	serious	serious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	77	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	78	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	79	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	80	9.7	9.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	81	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	82	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	83	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	84	10.5	10.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	85	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	86	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	87	mechanism	mechanism	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	88	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	89	action	action	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	90	21	21	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	91	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	92	20.4	20.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	93	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	94	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	95	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	96	21.0	21.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	97	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	98	Fixed	fix	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	99	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	100	dose	dose	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	101	combinations	combination	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	102	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	103	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	104	10.7	10.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	105	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	106	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	107	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	108	11.6	11.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	109	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	110	Biotechnological	biotechnological	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	111	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	112	biological	biological	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	113	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	114	31	31	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	115	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	116	30.1	30.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	117	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	118	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	119	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	120	26.3	26.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	121	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	122	Orphan	Orphan	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	123	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	124	product	product	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	125	16	16	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	126	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	127	15.5	15.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	128	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	129	16	16	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	130	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	131	16.8	16.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	132	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	133	Data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	134	do	do	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	135	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	136	sum	sum	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	137	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	138	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	139	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	140	because	because	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	141	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	142	rounding	round	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	143	errors	error	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	164	144	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	165	1	PIPs	PIPs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	165	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	165	3	Pediatric	Pediatric	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	165	4	Investigation	Investigation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	165	5	Plans	Plans	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	165	6	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	1	NCEs	NCEs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	3	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	4	chemical	chemical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	5	entities	entity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	6	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	7	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	8	agreed	agree	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	9	PIP	PIP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	166	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	1	Source	source	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	4	data	data	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	5	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	6	http://www.ema.europa.eu	http://www.ema.europa.eu	ADD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	7	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	8	search	search	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	9	until	until	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	10	September	September	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	11	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	167	13	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	1	Table	table	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	2	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	3	Distribution	distribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	4	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	5	pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	6	output	output	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	7	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	8	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	9	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	10	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	11	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	12	therapeutic	therapeutic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	13	area	area	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	14	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	15	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	17	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	18	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	19	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	20	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	21	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	22	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	23	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	24	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	25	measured	measure	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	26	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	27	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	28	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	29	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	30	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	31	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	32	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	33	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	34	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	35	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	36	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	37	Pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	38	output	output	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	39	related	relate	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	40	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	41	pediatric	pediatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	42	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	43	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	44	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	45	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	46	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	47	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	48	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	49	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	50	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	51	PIPs	pip	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	52	NCEs	NCEs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	53	Mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	54	per	per	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	55	106	106	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	56	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	57	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	58	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	59	DALYs	daly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	60	per	per	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	61	106	106	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	62	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	63	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	64	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	65	Number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	66	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	67	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	68	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	69	Number	number	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	70	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	71	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	72	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	73	Worldwide	Worldwide	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	74	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	75	Worldwide	Worldwide	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	76	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	77	Communicable	Communicable	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	78	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	79	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	80	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	81	19.4	19.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	82	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	83	19	19	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	84	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	85	20.0	20.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	86	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	87	10.1	10.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	88	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	89	84.6	84.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	90	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	91	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	92	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	93	43.7	43.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	94	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	95	406.5	406.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	96	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	97	74.1	74.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	98	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	99	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	100	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	101	24.6	24.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	102	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	103	Infectious	infectious	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	104	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	105	parasitic	parasitic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	106	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	107	12	12	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	108	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	109	11.6	11.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	110	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	111	12	12	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	112	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	113	12.6	12.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	114	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	115	4.6	4.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	116	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	117	38.6	38.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	118	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	119	.01	.01	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	120	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	121	3.4	3.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	122	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	123	176.5	176.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	124	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	125	32.2	32.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	126	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	127	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	128	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	129	3.8	3.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	130	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	131	Respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	132	infections	infection	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	133	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	134	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	135	4.8	4.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	136	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	137	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	138	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	139	4.2	4.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	140	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	141	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	142	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	143	17.3	17.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	144	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	145	.01	.01	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	146	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	147	2.0	2.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	148	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	149	76.2	76.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	150	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	151	13.9	13.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	152	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	153	.07	.07	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	154	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	155	1.9	1.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	156	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	157	Maternal	maternal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	158	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	159	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	160	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	161	1.9	1.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	162	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	163	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	164	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	165	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	166	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	167	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	168	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	169	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	170	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	171	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	172	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	173	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	174	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	175	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	176	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	177	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	178	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	179	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	180	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	181	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	182	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	183	Perinatal	perinatal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	184	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	185	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	186	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	187	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	188	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	189	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	190	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	191	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	192	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	193	3.2	3.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	194	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	195	26.8	26.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	196	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	197	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	198	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	199	38.3	38.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	200	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	201	126.4	126.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	202	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	203	23.1	23.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	204	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	205	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	206	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	207	16.2	16.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	208	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	209	Noncommunicable	noncommunicable	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	210	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	211	83	83	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	212	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	213	80.6	80.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	214	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	215	76	76	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	216	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	217	80.0	80.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	218	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	219	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	220	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	221	8.1	8.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	222	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	223	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	224	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	225	44.3	44.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	226	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	227	93.5	93.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	228	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	229	17.1	17.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	230	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	231	2.3	2.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	232	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	233	64.2	64.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	234	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	235	Malignant	malignant	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	236	neoplasms	neoplasm	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	237	16	16	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	238	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	239	15.5	15.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	240	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	241	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	242	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	243	15.8	15.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	244	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	245	.09	.09	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	246	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	247	0.7	0.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	248	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	249	.02	.02	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	250	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	251	7.1	7.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	252	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	253	3.2	3.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	254	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	255	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	256	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	257	.09	.09	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	258	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	259	2.4	2.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	260	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	261	Other	other	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	262	neoplasms	neoplasm	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	263	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	264	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	265	.01	.01	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	266	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	267	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	268	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	269	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	270	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	271	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	272	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	273	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	274	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	275	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	276	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	277	.01	.01	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	278	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	279	0.3	0.3	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	280	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	281	Diabetes	diabetes	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	282	mellitus	mellitus	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	283	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	284	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	285	8.7	8.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	286	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	287	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	288	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	289	7.4	7.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	290	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	291	.01	.01	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	292	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	293	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	294	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	295	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	296	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	297	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	298	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	299	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	300	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	301	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	302	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	303	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	304	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	305	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	306	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	307	Blood	blood	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	308	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	309	endocrine	endocrine	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	310	disorders	disorder	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	311	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	312	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	313	14.6	14.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	314	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	315	14	14	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	316	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	317	14.7	14.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	318	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	319	.05	.05	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	320	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	321	0.4	0.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	322	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	323	.01	.01	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	324	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	325	3.2	3.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	326	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	327	3.4	3.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	328	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	329	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	330	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	331	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	332	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	333	3.8	3.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	334	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	335	Neuropsychiatric	neuropsychiatric	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	336	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	337	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	338	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	339	8.7	8.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	340	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	341	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	342	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	343	9.5	9.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	344	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	345	.08	.08	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	346	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	347	0.6	0.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	348	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	349	.02	.02	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	350	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	351	4.8	4.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	352	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	353	30.6	30.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	354	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	355	5.6	5.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	356	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	357	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	358	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	359	24.6	24.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	360	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	361	Sense	sense	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	362	organ	organ	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	363	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	364	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	365	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	366	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	367	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	368	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	369	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	370	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	371	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	372	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	373	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	374	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	375	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	376	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	377	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	378	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	379	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	380	4.5	4.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	381	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	382	0.8	0.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	383	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	384	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	385	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	386	3.6	3.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	387	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	388	Cardiovascular	Cardiovascular	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	389	diseases	disease	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	390	12	12	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	391	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	392	11.6	11.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	393	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	394	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	395	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	396	11.6	11.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	397	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	398	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	399	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	400	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	401	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	402	.01	.01	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	403	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	404	2.7	2.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	405	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	406	5.1	5.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	407	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	408	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	409	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	410	.04	.04	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	411	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	412	1.1	1.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	413	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	414	Respiratory	respiratory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	415	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	416	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	417	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	418	3.9	3.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	419	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	420	4	4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	421	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	422	4.2	4.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	423	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	424	.06	.06	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	425	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	426	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	427	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	428	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	429	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	430	1.1	1.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	431	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	432	9.2	9.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	433	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	434	1.7	1.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	435	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	436	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	437	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	438	9.0	9.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	439	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	440	Digestive	Digestive	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	441	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	442	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	443	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	444	1.9	1.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	445	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	446	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	447	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	448	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	449	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	450	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	451	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	452	1.1	1.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	453	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	454	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	455	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	456	1.0	1.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	457	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	458	6.5	6.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	459	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	460	1.2	1.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	461	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	462	.05	.05	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	463	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	464	1.7	1.7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	465	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	466	Genitourinary	Genitourinary	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	467	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	468	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	469	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	470	1.9	1.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	471	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	472	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	473	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	474	2.1	2.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	475	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	476	.03	.03	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	477	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	478	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	479	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	480	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	481	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	482	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	483	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	484	1.6	1.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	485	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	486	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	487	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	488	.01	.01	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	489	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	490	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	491	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	492	Skin	skin	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	493	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	494	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	495	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	496	5.8	5.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	497	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	498	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	499	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	500	6.3	6.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	501	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	502	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	503	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	504	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	505	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	506	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	507	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	508	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	509	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	510	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	511	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	512	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	513	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	514	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	515	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	516	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	517	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	518	Musculoskeletal	Musculoskeletal	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	519	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	520	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	521	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	522	6.8	6.8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	523	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	524	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	525	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	526	6.3	6.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	527	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	528	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	529	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	530	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	531	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	532	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	533	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	534	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	535	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	536	1.6	1.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	537	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	538	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	539	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	540	.03	.03	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	541	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	542	0.9	0.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	543	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	544	Congenital	congenital	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	545	anomalies	anomaly	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	546	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	547	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	548	0.4	0.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	549	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	550	3.3	3.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	551	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	552	.07	.07	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	553	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	554	23.1	23.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	555	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	556	24.1	24.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	557	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	558	4.4	4.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	559	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	560	0.5	0.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	561	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	562	14.5	14.5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	563	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	564	Oral	oral	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	565	conditions	condition	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	566	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	567	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	568	.00	.00	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	569	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	570	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	571	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	572	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	573	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	574	0.0	0.0	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	575	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	576	2.2	2.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	577	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	578	0.4	0.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	579	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	580	.08	.08	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	581	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	582	2.2	2.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	583	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	584	Unintentional	unintentional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	585	injuries	injury	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	586	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	587	poisoning	poisoning	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	588	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	589	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	590	-	-	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	591	.03	.03	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	592	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	593	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	594	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	595	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	596	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	597	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	598	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	599	1.2	1.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	600	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	601	0.2	0.2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	602	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	603	.00	.00	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	604	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	605	0.1	0.1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	606	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	607	Total	Total	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	608	103	103	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	609	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	610	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	611	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	612	95	95	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	613	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	614	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	615	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	616	11.9	11.9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	617	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	618	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	619	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	620	0.3	0.3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	621	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	622	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	623	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	624	548.4	548.4	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	625	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	626	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	627	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	628	3.6	3.6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	629	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	630	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	631	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	632	Data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	633	do	do	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	634	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	635	sum	sum	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	636	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	637	100	100	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	638	%	%	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	639	because	because	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	640	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	641	rounding	round	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	642	errors	error	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	168	643	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	1	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	3	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	4	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	5	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	6	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	7	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	8	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	9	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	10	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	11	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	13	year	year	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	14	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	169	15	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	1	Burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	3	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	4	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	5	children	child	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	6	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	7	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	8	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	9	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	10	measured	measure	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	11	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	12	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	13	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	14	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	15	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	16	adjusted	adjust	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	17	life	life	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	18	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	19	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	20	DALYs	DALYs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	21	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	170	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	171	1	PIPs	PIPs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	171	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	171	3	Pediatric	Pediatric	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	171	4	Investigation	Investigation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	171	5	Plans	Plans	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	171	6	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	1	EU-25	EU-25	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	2	=	=	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	3	all	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	4	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	5	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	6	countries	country	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	7	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	8	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	172	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	1	*	*	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	2	NCEs	NCEs	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	3	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	4	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	5	chemical	chemical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	6	entities	entity	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	7	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	8	an	an	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	9	agreed	agree	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	10	PIP	PIP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	173	11	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	174	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	174	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	174	3	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	174	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	174	5	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	174	6	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	174	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	9	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	12	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	13	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	14	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	15	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	16	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	17	has	have	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	18	recently	recently	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	19	launched	launch	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	20	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	21	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	22	consultation	consultation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	23	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	24	its	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	25	future	future	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	26	actions	action	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	27	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	28	based	base	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	29	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	30	which	which	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	31	it	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	32	intends	intend	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	33	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	34	set	set	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	35	priorities	priority	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	36	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	37	coming	come	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	38	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	175	39	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	1	European	european	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	2	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	3	international	international	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	4	agencies	agency	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	6	including	include	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	7	medical	medical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	9	patient	patient	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	10	organizations	organization	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	13	pharmaceutical	pharmaceutical	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	14	industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	17	citizens	citizen	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	18	have	have	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	19	been	be	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	20	invited	invite	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	21	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	22	participate	participate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	23	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	24	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	25	document	document	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	26	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	27	“	"	``
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	28	Road	Road	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	29	Map	Map	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	30	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	31	2015	2015	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	32	”	"	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	33	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	34	31	31	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	35	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	36	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	37	including	include	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	38	debating	debate	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	39	how	how	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	40	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	41	approach	approach	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	42	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	43	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	44	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	45	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	46	promot-	promot-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	47	ing	ing	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	48	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	49	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	50	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	51	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	52	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	53	unmet	unmet	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	54	medical	medical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	55	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	56	areas	area	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	57	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	58	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	59	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	60	rare	rare	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	61	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	62	neglected	neglect	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	63	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	64	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	65	providing	provide	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	66	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	67	proposals	proposal	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	68	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	69	drug	drug	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	70	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	176	71	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	1	In	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	2	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	3	paper	paper	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	5	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	6	intended	intend	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	7	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	8	provide	provide	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	9	information	information	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	10	based	base	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	11	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	12	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	13	outcomes	outcome	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	14	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	15	decisions	decision	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	16	made	make	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	17	during	during	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	18	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	19	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	20	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	22	European	european	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	23	setting	setting	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	177	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	1	Pharmaceutical	pharmaceutical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	2	industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	3	leaders	leader	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	4	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	5	policymakers	policymaker	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	6	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	7	invited	invite	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	8	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	9	consider	consider	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	11	implications	implication	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	12	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	14	imbalance	imbalance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	15	explored	explore	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	16	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	17	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	18	paper	paper	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	20	establishing	establish	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	21	work	work	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	22	plans	plan	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	23	that	that	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	24	allow	allow	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	25	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	26	defining	define	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	27	future	future	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	28	priorities	priority	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	29	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	30	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	31	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	32	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	33	perspective	perspective	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	178	34	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	1	Acknowledgements	acknowledgement	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	2	We	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	3	would	would	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	4	like	like	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	5	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	6	acknowledge	acknowledge	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	8	editors	editor	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	11	peer	peer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	12	reviewers	reviewer	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	14	Silvio	Silvio	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	15	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	17	John	John	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	18	Joseph	Joseph	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	19	Borg	Borg	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	20	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	21	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	22	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	23	helpful	helpful	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	24	comments	comment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	25	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	26	our	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	27	submitted	submit	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	28	manuscript	manuscript	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	179	29	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	2	views	view	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	3	expressed	express	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	4	are	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	5	those	those	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	6	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	8	authors	author	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	10	should	should	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	11	not	not	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	12	be	be	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	13	understood	understand	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	14	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	15	quoted	quote	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	16	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	17	being	be	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	18	made	make	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	19	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	20	behalf	behalf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	21	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	22	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	23	reflecting	reflect	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	24	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	25	position	position	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	26	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	27	any	any	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	28	regulatory	regulatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	29	agency	agency	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	31	academic	academic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	32	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	33	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	34	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	35	institution	institution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	180	36	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	1	Author	author	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	2	details	detail	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	3	1Fundación	1Fundación	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	4	Instituto	Instituto	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	5	de	de	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	6	Investigación	Investigación	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	7	en	en	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	8	Servicios	Servicios	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	9	de	de	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	10	Salud	Salud	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	12	Valencia	Valencia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	14	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	181	15	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	1	2Division	2division	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	3	Pharmacoepidemiology	Pharmacoepidemiology	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	4	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	5	Pharmacovigilance	Pharmacovigilance	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	7	Spanish	Spanish	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	8	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	10	Healthcare	Healthcare	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	11	Products	Products	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	12	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	13	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	14	AEMPS	AEMPS	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	15	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	17	Ministry	Ministry	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	18	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	19	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	20	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	21	Social	Social	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	22	Policy	Policy	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	23	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	24	Madrid	Madrid	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	25	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	26	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	182	27	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	1	3Catalan	3Catalan	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	2	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	3	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	4	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	5	Information	Information	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	7	Assessment	Assessment	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	9	Quality	Quality	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	10	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	11	CAHIAQ	CAHIAQ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	14	Barcelona	Barcelona	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	16	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	183	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	1	4Department	4department	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	3	Preventive	Preventive	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	4	Medicine	Medicine	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	5	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	6	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	7	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	9	Rey	Rey	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	10	Juan	Juan	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	11	Carlos	Carlos	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	12	University	University	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	14	Madrid	Madrid	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	16	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	184	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	1	5Primary	5primary	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	2	Care	Care	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	3	General	General	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	4	Directorate	Directorate	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	6	Regional	Regional	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	7	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	8	Council	Council	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	10	Madrid	Madrid	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	12	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	185	13	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	1	6Department	6department	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	2	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	3	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	4	Information	Information	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	5	Systems	Systems	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	7	Regional	Regional	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	8	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	9	Council	Council	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	11	Madrid	Madrid	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	13	Spain	Spain	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	186	14	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	1	Authors	author	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	2	’	’	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	3	contributions	contribution	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	4	FCL	FCL	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	5	conceived	conceive	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	6	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	7	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	8	aims	aim	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	9	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	10	design	design	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	12	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	13	developed	develop	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	14	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	15	study	study	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	16	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	17	discussions	discussion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	18	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	19	AGA	AGA	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	20	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	21	EAM	EAM	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	22	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	23	RGM	RGM	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	25	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	26	CMG	CMG	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	187	27	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	1	FCL	FCL	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	2	performed	perform	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	4	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	5	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	6	drafted	draft	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	8	initial	initial	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	9	manuscript	manuscript	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	188	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	1	All	all	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	2	authors	author	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	3	contributed	contribute	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	4	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	5	interpretation	interpretation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	6	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	7	results	result	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	9	revised	revise	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	10	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	11	commented	comment	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	12	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	14	manuscript	manuscript	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	15	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	16	important	important	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	17	intellectual	intellectual	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	18	content	content	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	19	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	20	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	21	approved	approve	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	22	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	23	final	final	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	24	version	version	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	189	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	1	Competing	compete	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	2	interests	interest	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	3	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	4	authors	author	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	5	declare	declare	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	6	that	that	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	7	they	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	8	have	have	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	9	no	no	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	10	competing	compete	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	11	interests	interest	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	190	12	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	1	Received	receive	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	2	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	3	28	28	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	4	July	July	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	5	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	6	Accepted	accept	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	8	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	9	December	December	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	10	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	11	Published	publish	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	12	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	13	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	14	December	December	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	15	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	16	References	reference	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	17	1	1	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	18	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	19	de	de	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	20	Abajo	Abajo	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	21	FJ	FJ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	22	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	23	Medications	medication	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	24	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	25	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	26	solution	solution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	27	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	28	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	29	problem	problem	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	30	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	31	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	32	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	191	33	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	192	1	Brief	brief	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	192	2	overview	overview	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	192	3	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	192	4	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	192	5	pharmacoepidemiologic	pharmacoepidemiologic	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	192	6	objectives	objective	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	192	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	1	Rev	Rev	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	2	Esp	Esp	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	3	Salud	Salud	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	4	Publica	Publica	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	5	2001	2001	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	7	75(4):281	75(4):281	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	9	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	193	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	194	1	2	2	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	194	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	1	Commission	commission	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	2	European	european	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	3	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	4	Volume	volume	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	5	9A	9a	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	6	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	7	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	8	Rules	Rules	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	9	Governing	Governing	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	10	Medicinal	Medicinal	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	11	Products	Products	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	12	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	13	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	14	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	15	Union	Union	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	16	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	17	Pharmacovigilance	Pharmacovigilance	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	18	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	19	Medicinal	Medicinal	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	20	Products	Products	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	21	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	22	Human	Human	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	23	Use	Use	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	24	Brussels	Brussels	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	25	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	26	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	27	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	28	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	29	2008	2008	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	30	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	31	http://ec.europa.eu/enterprise/	http://ec.europa.eu/enterprise/	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	32	sectors	sector	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	33	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	34	pharmaceuticals	pharmaceutical	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	35	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	36	files	file	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	37	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	38	eudralex	eudralex	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	39	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	40	vol-9	vol-9	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	41	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	42	pdf	pdf	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	43	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	44	vol9a_09	vol9a_09	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	45	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	46	2008_en.pdf	2008_en.pdf	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	47	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	48	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	49	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	50	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	51	January	January	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	52	14	14	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	53	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	54	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	55	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	195	56	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	196	1	3	3	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	196	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	1	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	2	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	3	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	5	Central	central	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	6	authorisation	authorisation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	8	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	197	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	1	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	2	http://	http://	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	3	www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/	www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	4	general_content_000109.jsp&murl	general_content_000109.jsp&murl	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	5	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	6	menus	menu	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	7	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	8	about_us	about_us	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	9	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	10	about_us	about_us	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	198	11	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	1	jsp&mid	jsp&mid	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	2	=	=	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	3	WC0b01ac0580028a47	WC0b01ac0580028a47	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	4	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	6	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	7	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	8	December	December	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	9	13	13	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	11	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	199	13	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	200	1	4	4	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	200	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	1	Murray	Murray	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	2	CJL	CJL	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	4	Lopez	Lopez	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	5	AD	AD	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	6	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	7	The	The	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	8	Global	Global	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	9	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	11	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	201	12	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	1	A	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	2	comprehensive	comprehensive	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	3	assessment	assessment	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	4	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	5	mortality	mortality	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	6	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	7	disability	disability	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	8	from	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	9	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	11	injuries	injury	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	12	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	13	risk	risk	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	14	factors	factor	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	15	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	16	1990	1990	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	18	projected	project	VBD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	19	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	20	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	202	21	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	1	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	2	Harvard	Harvard	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	3	School	School	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	4	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	5	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	6	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	7	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	8	behalf	behalf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	9	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	11	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	12	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	13	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	14	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	15	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	16	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	17	Bank	Bank	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	18	Boston	Boston	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	19	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	20	Harvard	Harvard	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	21	University	University	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	22	Press	Press	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	23	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	24	1996	1996	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	203	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	204	1	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	204	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	1	Mathers	mather	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	2	CD	CD	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	4	Vos	Vos	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	5	ET	ET	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	7	Stevenson	Stevenson	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	8	CE	CE	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	10	Begg	Begg	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	11	SJ	SJ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	12	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	13	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	14	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	15	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	16	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	17	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	18	injury	injury	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	19	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	20	Australia	Australia	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	205	21	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	1	Bull	Bull	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	2	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	3	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	4	Organ	Organ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	5	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	6	2001:79:1076	2001:79:1076	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	7	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	8	1084	1084	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	206	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	207	1	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	207	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	1	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	2	Bank	Bank	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	3	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	4	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	5	Development	Development	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	6	Report	Report	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	7	1993	1993	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	9	Investing	invest	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	10	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	11	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	12	Washington	Washington	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	13	D.C.	D.C.	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	14	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	15	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	16	Bank	Bank	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	17	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	18	1993	1993	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	208	19	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	209	1	7	7	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	209	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	1	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	3	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	5	Ad	Ad	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	6	Hoc	Hoc	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	7	Committee	Committee	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	8	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	9	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	10	Research	Research	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	11	relating	relate	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	12	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	13	future	future	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	14	intervention	intervention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	15	options	option	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	16	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	17	investing	invest	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	18	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	19	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	20	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	21	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	22	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	23	Geneva	Geneva	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	24	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	25	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	26	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	27	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	28	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	29	1996	1996	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	210	30	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	211	1	8	8	LS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	211	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	1	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	2	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	4	Directorate	Directorate	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	5	General	General	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	6	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	7	Enterprise	Enterprise	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	9	Industry	industry	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	10	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	11	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	12	Register	Register	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	14	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	15	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	16	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	17	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	18	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	19	authorised	authorise	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	20	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	22	Community	Community	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	23	under	under	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	24	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	25	centralised	centralised	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	26	procedure	procedure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	212	27	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	1	Published	publish	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	2	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	3	accordance	accordance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	4	with	with	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	5	Article	Article	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	6	12	12	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	8	Regulation	Regulation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	9	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	10	EEC	EEC	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	11	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	12	No	no	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	13	2309/93	2309/93	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	14	Brussels	Brussels	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	15	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	16	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	17	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	18	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	19	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	20	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	21	http://ec	http://ec	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	213	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	1	europa.eu/enterprise/sectors/pharmaceuticals/documents/community-	europa.eu/enterprise/sectors/pharmaceuticals/documents/community-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	2	register	register	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	3	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	4	html	html	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	5	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	6	index_en.htm	index_en.htm	ADD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	7	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	9	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	10	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	11	February	February	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	12	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	14	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	15	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	214	16	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	215	1	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	215	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	1	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	2	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	3	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	5	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	6	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	7	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	8	Assessment	Assessment	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	9	Report	Report	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	10	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	11	EPAR	EPAR	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	12	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	13	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	14	authorised	authorise	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	15	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	16	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	17	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	18	human	human	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	19	use	use	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	20	London	London	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	21	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	22	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	23	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	24	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	25	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	26	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	27	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	28	http://www.ema.europa.eu/htms/human/epar/a	http://www.ema.europa.eu/htms/human/epar/a	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	216	29	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	1	htm	htm	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	2	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	4	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	5	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	6	February	February	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	7	2	2	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	9	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	10	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	217	11	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	218	1	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	218	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	1	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	3	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	5	The	The	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	6	Global	Global	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	7	Burden	Burden	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	8	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	9	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	10	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	11	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	12	update	update	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	13	Geneva	Geneva	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	14	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	15	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	16	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	17	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	18	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	19	2008	2008	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	20	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	21	http://www.who.int/evidence/	http://www.who.int/evidence/	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	22	bod	bod	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	23	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	25	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	26	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	27	January	January	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	28	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	29	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	30	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	31	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	219	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	220	1	11	11	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	220	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	1	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	3	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	5	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	6	country	country	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	7	estimates	estimate	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	221	8	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	1	Death	death	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	2	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	3	DALY	DALY	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	4	estimates	estimate	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	5	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	6	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	7	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	8	cause	cause	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	9	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	10	WHO	who	WP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	11	Member	Member	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	12	States	States	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	13	Geneva	Geneva	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	14	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	15	World	World	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	16	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	17	Organization	Organization	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	18	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	19	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	20	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	21	http://www.who.int/healthinfo/global_burden_disease/	http://www.who.int/healthinfo/global_burden_disease/	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	22	gbddeathdalycountryestimates2004.xls	gbddeathdalycountryestimates2004.xls	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	23	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	25	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	26	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	27	January	January	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	28	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	29	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	30	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	31	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	222	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	223	1	12	12	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	223	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	1	Barbui	Barbui	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	2	C	C	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	4	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	5	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	6	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	7	Regulatory	regulatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	8	policies	policy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	9	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	10	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	11	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	12	psychiatric	psychiatric	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	13	disorders	disorder	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	14	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	15	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	16	Europe	Europe	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	17	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	18	target	target	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	224	19	?	?	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	1	Br	br	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	2	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	3	Psychiatry	Psychiatry	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	4	2007	2007	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	6	190:91	190:91	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	7	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	8	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	225	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	226	1	13	13	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	226	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	1	Apolone	Apolone	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	2	G	G	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	4	Joppi	Joppi	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	5	R	R	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	7	Bertele	Bertele	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	8	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	9	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	11	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	12	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	13	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	14	Ten	ten	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	15	years	year	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	17	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	18	approvals	approval	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	19	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	20	anticancer	anticancer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	21	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	22	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	23	Europe	Europe	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	24	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	25	regulatory	regulatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	26	policy	policy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	27	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	28	guidance	guidance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	29	documents	document	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	30	need	need	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	31	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	32	find	find	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	33	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	34	balance	balance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	35	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	36	different	different	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	37	pressures	pressure	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	227	38	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	1	Br	br	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	2	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	3	Cancer	Cancer	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	4	2005	2005	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	6	93(5):504	93(5):504	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	7	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	8	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	228	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	229	1	14	14	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	229	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	1	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	2	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	4	Bertele	Bertele	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	5	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	6	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	8	Efficacy	efficacy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	10	safety	safety	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	12	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	13	cost	cost	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	14	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	15	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	16	anticancer	anticancer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	17	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	230	18	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	231	1	BMJ	BMJ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	231	2	2002	2002	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	231	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	231	4	325(7358):269	325(7358):269	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	231	5	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	231	6	71	71	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	231	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	232	1	15	15	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	232	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	1	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	2	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	4	Bertele	Bertele	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	5	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	6	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	8	Efficacy	efficacy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	10	safety	safety	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	11	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	12	cost	cost	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	14	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	15	cardiovascular	cardiovascular	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	16	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	17	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	18	a	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	19	survey	survey	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	233	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	1	Eur	Eur	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	2	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	3	Clin	Clin	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	4	Pharmacol	Pharmacol	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	5	2003	2003	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	7	59(8	59(8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	8	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	9	9):701	9):701	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	10	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	11	6	6	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	234	12	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	235	1	16	16	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	235	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	1	Bertele	bertele	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	2	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	3	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	5	Assisi	Assisi	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	6	A	A	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	7	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	8	Di	Di	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	9	Muzio	Muzio	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	10	V	V	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	11	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	12	Renzo	Renzo	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	13	D	D	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	14	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	15	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	16	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	17	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	18	New	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	19	antirheumatic	antirheumatic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	20	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	21	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	22	any	any	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	23	real	real	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	24	added	add	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	25	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	236	26	?	?	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	1	A	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	2	critical	critical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	3	overview	overview	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	4	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	5	regulatory	regulatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	6	criteria	criterion	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	7	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	8	their	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	9	marketing	marketing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	10	approval	approval	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	237	11	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	1	Eur	Eur	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	2	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	3	Clin	Clin	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	4	Pharmacol	Pharmacol	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	5	2007	2007	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	7	63(9):879	63(9):879	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	9	89	89	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	238	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	239	1	17	17	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	239	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	1	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	2	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	4	Bertele	Bertele	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	5	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	6	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	8	Efficacy	efficacy	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	10	safety	safety	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	11	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	12	cost	cost	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	13	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	14	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	15	drugs	drug	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	16	acting	act	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	17	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	18	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	19	central	central	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	20	nervous	nervous	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	21	system	system	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	240	22	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	1	Eur	Eur	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	2	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	3	Clin	Clin	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	4	Pharmacol	Pharmacol	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	5	2003	2003	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	7	59(1):79	59(1):79	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	8	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	9	84	84	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	241	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	242	1	18	18	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	242	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	1	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	2	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	4	Bertele	Bertele	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	5	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	6	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	8	How	how	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	9	can	can	MD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	10	we	-PRON-	PRP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	11	regulate	regulate	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	12	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	13	better	well	RBR
work_nr3tsrvjhrhkjnmakmy6hwxcc4	243	14	?	?	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	244	1	BMJ	BMJ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	244	2	2007	2007	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	244	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	244	4	335(7624):803	335(7624):803	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	244	5	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	244	6	5	5	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	244	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	245	1	19	19	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	245	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	1	Bassi	Bassi	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	2	Li	Li	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	4	Bertele	Bertele	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	5	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	6	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	7	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	8	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	9	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	10	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	11	European	european	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	12	regulatory	regulatory	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	13	policies	policy	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	14	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	15	medicines	medicine	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	16	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	17	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	18	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	19	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	246	20	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	1	Eur	Eur	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	2	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	3	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	4	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	5	2003	2003	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	7	13(3):246	13(3):246	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	9	51	51	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	247	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	248	1	20	20	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	248	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	1	Garattini	Garattini	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	2	S	S	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	4	Bertele	Bertele	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	5	’	'	''
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	6	V	v	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	7	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	8	Adjusting	Adjusting	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	9	Europe	Europe	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	10	’s	’s	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	11	drug	drug	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	12	regulation	regulation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	13	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	14	public	public	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	15	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	16	needs	need	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	249	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	250	1	Lancet	Lancet	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	250	2	2001	2001	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	250	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	250	4	358:64	358:64	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	250	5	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	250	6	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	250	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	251	1	21	21	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	251	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	1	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	2	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	4	Pharmaforum	Pharmaforum	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	5	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	6	From	from	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	7	assessing	assess	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	8	innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	9	value	value	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	11	pharmaceuticals	pharmaceutical	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	12	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	13	pricing	pricing	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	14	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	15	reimbursement	reimbursement	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	16	decisions	decision	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	17	Brussels	Brussels	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	18	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	19	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	20	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	21	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	22	2008	2008	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	23	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	24	http://ec.europa.eu/pharmaforum/docs/	http://ec.europa.eu/pharmaforum/docs/	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	25	pricing_assessing_en.pdf	pricing_assessing_en.pdf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	26	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	27	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	28	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	29	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	30	February	February	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	31	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	32	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	33	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	34	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	252	35	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	253	1	22	22	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	253	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	1	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	2	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	4	Pharmaforum	Pharmaforum	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	5	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	6	Characterisation	characterisation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	7	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	8	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	9	Value	Value	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	11	Innovative	innovative	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	12	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	13	Brussels	Brussels	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	14	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	15	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	16	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	17	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	18	2008	2008	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	19	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	20	http://ec.europa	http://ec.europa	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	254	21	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	1	eu	eu	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	2	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	3	pharmaforum	pharmaforum	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	4	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	5	docs	docs	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	6	/	/	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	7	pricing_innovative_en.pdf	pricing_innovative_en.pdf	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	8	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	10	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	11	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	12	February	February	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	13	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	14	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	15	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	16	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	255	17	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	256	1	23	23	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	256	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	1	Dorsey	Dorsey	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	2	ER	ER	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	4	de	de	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	5	Roulet	Roulet	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	6	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	7	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	8	Thompson	Thompson	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	9	JP	JP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	11	Reminick	Reminick	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	12	JI	JI	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	13	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	14	Thai	Thai	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	15	A	A	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	17	White	White	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	18	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	19	Stellato	Stellato	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	20	Z	Z	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	21	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	22	Beck	Beck	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	23	CA	CA	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	24	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	25	George	George	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	26	BP	BP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	27	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	28	Moses	Moses	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	29	H	H	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	30	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	31	Funding	funding	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	32	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	33	US	US	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	34	biomedical	biomedical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	35	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	36	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	37	2003-	2003-	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	38	2008	2008	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	257	39	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	1	JAMA	JAMA	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	2	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	3	3	3	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	6	303(2):137	303(2):137	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	7	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	8	43	43	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	258	9	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	259	1	24	24	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	259	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	1	Gross	Gross	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	2	CP	CP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	4	Anderson	Anderson	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	5	GF	GF	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	7	Powe	Powe	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	8	NR	NR	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	9	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	10	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	11	relation	relation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	12	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	13	funding	funding	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	14	by	by	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	15	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	16	National	National	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	17	Institutes	Institutes	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	18	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	19	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	20	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	21	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	22	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	23	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	24	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	260	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	1	N	N	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	2	Engl	Engl	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	3	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	4	Med	Med	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	5	1999	1999	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	7	340(24):1881	340(24):1881	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	9	7	7	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	261	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	262	1	25	25	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	262	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	1	Curry	Curry	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	2	CW	CW	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	4	De	De	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	5	AK	AK	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	7	Ikeda	Ikeda	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	8	RM	RM	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	10	Thacker	Thacker	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	11	SB	SB	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	12	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	13	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	14	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	15	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	16	funding	funding	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	17	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	18	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	19	Centers	Centers	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	20	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	21	Disease	Disease	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	22	Control	Control	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	23	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	24	Prevention	Prevention	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	263	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	1	Am	be	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	2	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	3	Prev	Prev	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	4	Med	Med	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	5	2006	2006	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	7	30(3):269	30(3):269	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	9	76	76	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	264	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	265	1	26	26	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	265	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	2	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	3	F	F	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	5	Álvarez	Álvarez	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	6	Martin	Martin	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	7	E	E	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	9	Gènova	Gènova	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	10	Maleras	Maleras	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	11	R	R	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	13	Morant	Morant	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	14	Ginestar	Ginestar	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	15	C	C	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	16	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	17	Relationship	relationship	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	18	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	19	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	20	funding	funding	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	21	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	22	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	23	Spanish	Spanish	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	24	National	National	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	25	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	26	System	System	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	27	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	28	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	29	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	30	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	31	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	266	32	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	1	Rev	Rev	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	2	Esp	Esp	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	3	Salud	Salud	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	4	Publica	Publica	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	5	2009	2009	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	7	83(1):137	83(1):137	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	8	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	9	51	51	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	267	10	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	268	1	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	268	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	268	3	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	268	4	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	268	5	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	268	6	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	268	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	9	9	9	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	12	http://www.ncbi.nlm.nih.gov/pubmed/11693067?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/11693067?dopt=abstract	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	13	http://www.ncbi.nlm.nih.gov/pubmed/11693067?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/11693067?dopt=abstract	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	14	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/files/eudralex/vol-9/pdf/vol9a_09-2008_en.pdf	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/files/eudralex/vol-9/pdf/vol9a_09-2008_en.pdf	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	15	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/files/eudralex/vol-9/pdf/vol9a_09-2008_en.pdf	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/files/eudralex/vol-9/pdf/vol9a_09-2008_en.pdf	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	16	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028a47	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028a47	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	17	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028a47	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028a47	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	18	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028a47	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028a47	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	19	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=WC0b01ac0580028a47	http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000109.jsp&murl=menus/about_us/about_us.jsp&mid=wc0b01ac0580028a47	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	20	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/community-register/html/index_en.htm	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/community-register/html/index_en.htm	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	21	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/community-register/html/index_en.htm	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/community-register/html/index_en.htm	WRB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	22	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/community-register/html/index_en.htm	http://ec.europa.eu/enterprise/sectors/pharmaceuticals/documents/community-register/html/index_en.htm	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	23	http://www.ema.europa.eu/htms/human/epar/a.htm	http://www.ema.europa.eu/htms/human/epar/a.htm	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	24	http://www.ema.europa.eu/htms/human/epar/a.htm	http://www.ema.europa.eu/htms/human/epar/a.htm	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	25	http://www.who.int/evidence/bod	http://www.who.int/evidence/bod	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	26	http://www.who.int/evidence/bod	http://www.who.int/evidence/bod	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	27	http://www.who.int/healthinfo/global_burden_disease/gbddeathdalycountryestimates2004.xls	http://www.who.int/healthinfo/global_burden_disease/gbddeathdalycountryestimates2004.xls	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	28	http://www.who.int/healthinfo/global_burden_disease/gbddeathdalycountryestimates2004.xls	http://www.who.int/healthinfo/global_burden_disease/gbddeathdalycountryestimates2004.xls	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	29	http://www.ncbi.nlm.nih.gov/pubmed/17267922?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/17267922?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	30	http://www.ncbi.nlm.nih.gov/pubmed/17267922?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/17267922?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	31	http://www.ncbi.nlm.nih.gov/pubmed/16136026?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/16136026?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	32	http://www.ncbi.nlm.nih.gov/pubmed/16136026?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/16136026?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	33	http://www.ncbi.nlm.nih.gov/pubmed/16136026?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/16136026?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	34	http://www.ncbi.nlm.nih.gov/pubmed/12153927?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/12153927?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	35	http://www.ncbi.nlm.nih.gov/pubmed/12961050?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/12961050?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	36	http://www.ncbi.nlm.nih.gov/pubmed/12961050?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/12961050?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	37	http://www.ncbi.nlm.nih.gov/pubmed/17646975?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/17646975?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	38	http://www.ncbi.nlm.nih.gov/pubmed/17646975?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/17646975?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	39	http://www.ncbi.nlm.nih.gov/pubmed/17646975?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/17646975?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	40	http://www.ncbi.nlm.nih.gov/pubmed/12743674?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/12743674?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	41	http://www.ncbi.nlm.nih.gov/pubmed/12743674?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/12743674?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	42	http://www.ncbi.nlm.nih.gov/pubmed/17947785?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/17947785?dopt=abstract	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	43	http://www.ncbi.nlm.nih.gov/pubmed/14533728?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/14533728?dopt=abstract	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	44	http://www.ncbi.nlm.nih.gov/pubmed/14533728?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/14533728?dopt=abstract	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	45	http://www.ncbi.nlm.nih.gov/pubmed/11454401?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/11454401?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	46	http://www.ncbi.nlm.nih.gov/pubmed/11454401?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/11454401?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	47	http://ec.europa.eu/pharmaforum/docs/pricing_assessing_en.pdf	http://ec.europa.eu/pharmaforum/docs/pricing_assessing_en.pdf	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	48	http://ec.europa.eu/pharmaforum/docs/pricing_assessing_en.pdf	http://ec.europa.eu/pharmaforum/docs/pricing_assessing_en.pdf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	49	http://ec.europa.eu/pharmaforum/docs/pricing_innovative_en.pdf	http://ec.europa.eu/pharmaforum/docs/pricing_innovative_en.pdf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	50	http://ec.europa.eu/pharmaforum/docs/pricing_innovative_en.pdf	http://ec.europa.eu/pharmaforum/docs/pricing_innovative_en.pdf	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	51	http://www.ncbi.nlm.nih.gov/pubmed/20068207?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/20068207?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	52	http://www.ncbi.nlm.nih.gov/pubmed/20068207?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/20068207?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	53	http://www.ncbi.nlm.nih.gov/pubmed/10369852?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/10369852?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	54	http://www.ncbi.nlm.nih.gov/pubmed/10369852?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/10369852?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	55	http://www.ncbi.nlm.nih.gov/pubmed/16476645?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/16476645?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	56	http://www.ncbi.nlm.nih.gov/pubmed/16476645?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/16476645?dopt=abstract	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	57	http://www.ncbi.nlm.nih.gov/pubmed/19495495?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/19495495?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	58	http://www.ncbi.nlm.nih.gov/pubmed/19495495?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/19495495?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	59	27	27	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	269	60	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	1	Global	Global	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	2	Forum	Forum	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	3	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	4	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	5	Research	Research	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	6	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	7	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	8	10/90	10/90	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	9	Report	Report	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	10	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	11	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	12	Research	Research	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	13	2000	2000	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	14	Geneva	Geneva	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	15	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	16	Global	Global	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	17	Forum	Forum	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	18	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	19	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	20	Research	Research	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	21	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	22	2000	2000	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	23	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	24	http://www	http://www	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	270	25	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	1	globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-	globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	2	90-Report	90-report	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	3	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	4	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	5	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	6	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	7	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	8	Research-2000	Research-2000	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	9	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	10	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	11	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	12	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	13	April	April	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	14	13	13	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	15	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	16	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	17	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	271	18	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	272	1	28	28	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	272	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	1	Isaakidis	Isaakidis	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	2	P	P	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	4	Swingler	Swingler	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	5	GH	GH	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	7	Pienaar	Pienaar	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	8	E	E	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	10	Volmink	Volmink	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	11	J	J	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	12	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	13	Ioannidis	Ioannidis	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	14	JP	JP	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	15	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	16	Relation	relation	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	17	between	between	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	18	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	19	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	20	disease	disease	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	21	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	22	randomised	randomised	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	23	evidence	evidence	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	24	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	25	sub	sub	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	26	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	27	Saharan	Saharan	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	28	Africa	Africa	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	29	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	30	survey	survey	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	31	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	32	research	research	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	273	33	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	274	1	BMJ	BMJ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	274	2	2002	2002	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	274	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	274	4	324(7339):702	324(7339):702	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	274	5	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	275	1	29	29	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	275	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	1	Yach	yach	UH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	2	D	d	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	4	Hawkes	Hawkes	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	5	C	C	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	6	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	7	Gould	Gould	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	8	CL	CL	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	9	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	10	Hofman	Hofman	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	11	KJ	KJ	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	12	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	13	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	14	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	15	burden	burden	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	16	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	17	chronic	chronic	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	18	diseases	disease	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	19	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	20	overcoming	overcome	VBG
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	21	impediments	impediment	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	22	to	to	TO
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	23	prevention	prevention	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	24	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	25	control	control	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	276	26	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	277	1	JAMA	JAMA	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	277	2	2004	2004	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	277	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	277	4	291(21):2616	291(21):2616	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	277	5	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	277	6	22	22	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	277	7	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	278	1	30	30	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	278	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	279	1	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	279	2	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	279	3	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	279	4	White	White	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	279	5	Paper	Paper	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	279	6	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	1	Together	together	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	2	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	3	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	5	A	a	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	6	Strategic	Strategic	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	7	Approach	Approach	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	8	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	9	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	10	EU	EU	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	11	2008	2008	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	12	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	13	2013	2013	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	14	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	15	COM(2007	com(2007	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	16	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	17	630	630	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	18	final	final	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	19	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	20	Brussels	Brussels	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	21	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	22	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	23	Commission	Commission	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	24	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	25	2007	2007	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	26	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	27	http://ec.europa.eu/health/ph_overview/Documents/	http://ec.europa.eu/health/ph_overview/documents/	FW
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	28	strategy_wp_en.pdf	strategy_wp_en.pdf	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	29	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	30	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	31	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	32	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	33	January	January	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	34	14	14	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	35	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	36	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	37	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	280	38	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	281	1	31	31	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	281	2	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	1	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	2	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	3	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	4	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	5	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	6	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	7	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	8	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	9	Road	Road	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	10	Map	Map	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	11	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	12	2015	2015	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	13	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	14	The	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	15	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	16	’s	’s	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	17	Contribution	Contribution	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	18	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	19	Science	Science	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	20	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	21	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	22	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	23	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	282	24	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	1	Draft	draft	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	2	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	3	Public	Public	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	4	Consultation	Consultation	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	5	London	London	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	6	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	7	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	8	Medicines	Medicines	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	9	Agency	Agency	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	10	;	;	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	11	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	12	[	[	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	13	http://www.ema	http://www.ema	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	283	14	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	1	europa.eu/pdfs/general/direct/directory/29989509en.pdf	europa.eu/pdfs/general/direct/directory/29989509en.pdf	NFP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	2	]	]	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	3	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	4	(	(	-LRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	5	accessed	access	VBN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	6	April	April	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	7	02	02	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	8	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	9	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	10	)	)	-RRB-
work_nr3tsrvjhrhkjnmakmy6hwxcc4	284	11	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	1	doi:10.1186/1478	doi:10.1186/1478	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	2	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	3	7954	7954	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	4	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	5	8	8	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	6	-	-	SYM
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	7	34	34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	8	Cite	cite	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	9	this	this	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	10	article	article	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	11	as	as	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	12	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	13	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	14	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	15	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	16	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	17	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	18	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	285	19	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	1	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	2	Does	do	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	3	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	4	development	development	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	5	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	6	new	new	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	7	medicinal	medicinal	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	8	products	product	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	9	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	10	the	the	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	11	European	European	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	12	Union	Union	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	13	address	address	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	14	global	global	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	15	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	16	regional	regional	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	17	health	health	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	18	concerns	concern	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	286	19	?	?	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	287	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	287	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	287	3	Metrics	Metrics	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	287	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	287	5	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	287	6	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	1	Submit	submit	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	2	your	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	3	next	next	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	4	manuscript	manuscript	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	5	to	to	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	6	BioMed	BioMed	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	7	Central	Central	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	8	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	9	take	take	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	10	full	full	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	11	advantage	advantage	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	12	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	13	:	:	:
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	14	•	•	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	15	Convenient	convenient	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	16	online	online	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	17	submission	submission	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	18	•	•	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	19	Thorough	thorough	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	20	peer	peer	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	21	review	review	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	22	•	•	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	23	No	no	DT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	24	space	space	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	25	constraints	constraint	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	26	or	or	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	27	color	color	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	28	figure	figure	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	29	charges	charge	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	30	•	•	VBP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	31	Immediate	immediate	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	32	publication	publication	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	33	on	on	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	34	acceptance	acceptance	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	35	•	•	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	36	Inclusion	Inclusion	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	37	in	in	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	38	PubMed	PubMed	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	39	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	40	CAS	CAS	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	41	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	42	Scopus	Scopus	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	43	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	44	Google	Google	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	45	Scholar	Scholar	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	46	•	•	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	47	Research	Research	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	48	which	which	WDT
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	49	is	be	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	50	freely	freely	RB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	51	available	available	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	52	for	for	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	53	redistribution	redistribution	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	54	Submit	submit	VB
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	55	your	-PRON-	PRP$
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	56	manuscript	manuscript	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	57	at	at	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	58	www.biomedcentral.com/submit	www.biomedcentral.com/submit	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	59	Catalá	Catalá	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	60	-	-	HYPH
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	61	López	López	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	62	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	63	et	et	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	64	al	al	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	288	65	.	.	.
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	1	Population	Population	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	2	Health	Health	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	3	Metrics	Metrics	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	4	2010	2010	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	5	,	,	,
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	6	8:34	8:34	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	7	http://www.pophealthmetrics.com/content/8/1/34	http://www.pophealthmetrics.com/content/8/1/34	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	8	Page	Page	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	9	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	10	of	of	IN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	11	10	10	CD
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	12	http://www.globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-90-Report-on-Health-Research-2000	http://www.globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-90-Report-on-Health-Research-2000	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	13	http://www.globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-90-Report-on-Health-Research-2000	http://www.globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-90-Report-on-Health-Research-2000	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	14	http://www.globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-90-Report-on-Health-Research-2000	http://www.globalforumhealth.org/layout/set/print/Media-Publications/Publications/10-90-Report-on-Health-Research-2000	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	15	http://www.ncbi.nlm.nih.gov/pubmed/11909786?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/11909786?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	16	http://www.ncbi.nlm.nih.gov/pubmed/11909786?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/11909786?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	17	http://www.ncbi.nlm.nih.gov/pubmed/11909786?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/11909786?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	18	http://www.ncbi.nlm.nih.gov/pubmed/15173153?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/15173153?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	19	http://www.ncbi.nlm.nih.gov/pubmed/15173153?dopt=Abstract	http://www.ncbi.nlm.nih.gov/pubmed/15173153?dopt=Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	20	http://ec.europa.eu/health/ph_overview/Documents/strategy_wp_en.pdf	http://ec.europa.eu/health/ph_overview/Documents/strategy_wp_en.pdf	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	21	http://ec.europa.eu/health/ph_overview/Documents/strategy_wp_en.pdf	http://ec.europa.eu/health/ph_overview/documents/strategy_wp_en.pdf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	22	http://www.ema.europa.eu/pdfs/general/direct/directory/29989509en.pdf	http://www.ema.europa.eu/pdfs/general/direct/directory/29989509en.pdf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	23	http://www.ema.europa.eu/pdfs/general/direct/directory/29989509en.pdf	http://www.ema.europa.eu/pdfs/general/direct/directory/29989509en.pdf	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	24	Abstract	Abstract	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	25	Background	Background	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	26	Methods	Methods	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	27	Results	Results	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	28	Conclusions	Conclusions	NNPS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	29	Background	Background	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	30	Methods	Methods	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	31	Study	Study	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	32	design	design	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	33	and	and	CC
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	34	data	datum	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	35	sources	source	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	36	Statistical	statistical	JJ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	37	analysis	analysis	NN
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	38	Results	result	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	39	Discussion	Discussion	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	40	Acknowledgements	Acknowledgements	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	41	Author	Author	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	42	details	detail	VBZ
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	43	Authors	author	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	44	'	'	POS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	45	contributions	contribution	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	46	Competing	Competing	NNP
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	47	interests	interest	NNS
work_nr3tsrvjhrhkjnmakmy6hwxcc4	289	48	References	reference	NNS